Page last updated: 2024-08-07 17:30:01
Histone deacetylase 6
A histone deacetylase 6 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UBN7]
Synonyms
HD6;
EC 3.5.1.98;
Tubulin-lysine deacetylase HDAC6;
3.5.1.-
Research
Bioassay Publications (484)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (0.21) | 18.2507 |
2000's | 77 (15.91) | 29.6817 |
2010's | 280 (57.85) | 24.3611 |
2020's | 126 (26.03) | 2.80 |
Compounds (106)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
gamma-aminobutyric acid | Homo sapiens (human) | Ki | 8.1900 | 1 | 1 |
butyric acid | Homo sapiens (human) | IC50 | 2,000.0000 | 1 | 1 |
butyric acid | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
celecoxib | Homo sapiens (human) | IC50 | 1.1400 | 2 | 2 |
ci 994 | Homo sapiens (human) | IC50 | 31.2124 | 10 | 17 |
ci 994 | Homo sapiens (human) | Ki | 0.0950 | 1 | 3 |
clioquinol | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
valproic acid | Homo sapiens (human) | IC50 | 2,290.0020 | 5 | 5 |
valproic acid | Homo sapiens (human) | Ki | 564.0000 | 1 | 1 |
ebselen | Homo sapiens (human) | IC50 | 6.5333 | 3 | 3 |
fluconazole | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
beta-thujaplicin | Homo sapiens (human) | Ki | 2.5000 | 1 | 1 |
4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide | Homo sapiens (human) | IC50 | 0.8053 | 3 | 3 |
entinostat | Homo sapiens (human) | IC50 | 16.4399 | 44 | 62 |
4-phenylbutyric acid | Homo sapiens (human) | IC50 | 240.0000 | 1 | 1 |
4-phenylbutyric acid | Homo sapiens (human) | Ki | 2.8000 | 1 | 1 |
pomiferin | Homo sapiens (human) | IC50 | 1.0500 | 1 | 1 |
ppm 18 | Homo sapiens (human) | IC50 | 5.5400 | 2 | 2 |
pyroxamide | Homo sapiens (human) | IC50 | 5.1000 | 2 | 2 |
pyroxamide | Homo sapiens (human) | Ki | 0.0048 | 1 | 1 |
suberoyl bis-hydroxamic acid | Homo sapiens (human) | IC50 | 2.0300 | 1 | 1 |
suberoyl bis-hydroxamic acid | Homo sapiens (human) | Ki | 0.0145 | 1 | 1 |
scriptaid | Homo sapiens (human) | IC50 | 0.1194 | 5 | 5 |
scriptaid | Homo sapiens (human) | Ki | 0.0002 | 1 | 1 |
4-phenylbutyric acid, sodium salt | Homo sapiens (human) | Ki | 6.3400 | 1 | 1 |
fenofibrate | Homo sapiens (human) | IC50 | 75.0000 | 2 | 2 |
fenofibrate | Homo sapiens (human) | Ki | 75.0000 | 1 | 1 |
imatinib | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
vorinostat | Homo sapiens (human) | IC50 | 1.2867 | 412 | 450 |
vorinostat | Homo sapiens (human) | Ki | 0.3047 | 14 | 16 |
benzohydroxamic acid | Homo sapiens (human) | IC50 | 1.2760 | 3 | 3 |
acetylcysteine | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
camptothecin | Homo sapiens (human) | IC50 | 0.0500 | 1 | 1 |
daunorubicin | Homo sapiens (human) | IC50 | 0.0200 | 1 | 1 |
lovastatin | Homo sapiens (human) | IC50 | 16.2850 | 1 | 1 |
atorvastatin | Homo sapiens (human) | IC50 | 14.4660 | 1 | 1 |
bendamustine | Homo sapiens (human) | IC50 | 0.0100 | 1 | 1 |
nicotinohydroxamic acid | Homo sapiens (human) | IC50 | 0.6790 | 1 | 1 |
osajin | Homo sapiens (human) | IC50 | 6.5300 | 1 | 1 |
8-mercaptoquinoline | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
zm 241385 | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
lapatinib | Homo sapiens (human) | IC50 | 55.0000 | 2 | 2 |
N-hydroxy-2-phenylacetamide | Homo sapiens (human) | IC50 | 1.1000 | 1 | 1 |
n-hydroxy-2,2-diphenylacetamide | Homo sapiens (human) | IC50 | 12.7443 | 6 | 8 |
bortezomib | Homo sapiens (human) | IC50 | 69.4400 | 1 | 1 |
trapoxin a | Homo sapiens (human) | IC50 | 0.0047 | 3 | 3 |
actinonin | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
e-z cinnamic acid | Homo sapiens (human) | Ki | 0.0082 | 1 | 1 |
trichostatin a | Homo sapiens (human) | IC50 | 0.2559 | 100 | 120 |
trichostatin a | Homo sapiens (human) | Ki | 0.0730 | 7 | 7 |
caffeic acid | Homo sapiens (human) | IC50 | 2,540.0000 | 1 | 1 |
caffeic acid | Homo sapiens (human) | Ki | 10.8400 | 1 | 1 |
curcumin | Homo sapiens (human) | IC50 | 187.0000 | 1 | 1 |
chlorogenic acid | Homo sapiens (human) | IC50 | 258.3333 | 3 | 3 |
chlorogenic acid | Homo sapiens (human) | Ki | 0.1350 | 1 | 1 |
zd 6474 | Homo sapiens (human) | IC50 | 10.0000 | 3 | 3 |
desmethylanethol trithione | Homo sapiens (human) | IC50 | 0.4500 | 2 | 2 |
ex 527 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
sodium butyrate | Homo sapiens (human) | IC50 | 360.0000 | 3 | 3 |
sodium butyrate | Homo sapiens (human) | Ki | 365.0000 | 1 | 1 |
5'-o-caffeoylquinic acid | Homo sapiens (human) | IC50 | 185.2000 | 2 | 2 |
harmine | Homo sapiens (human) | IC50 | 10.0000 | 3 | 3 |
aureusidin | Homo sapiens (human) | IC50 | 33.5000 | 2 | 2 |
romidepsin | Homo sapiens (human) | IC50 | 35.4553 | 15 | 15 |
romidepsin | Homo sapiens (human) | Ki | 0.1065 | 3 | 3 |
cinnamoylhydroxamic acid | Homo sapiens (human) | IC50 | 0.0220 | 1 | 1 |
3',4'-dihydroxyaurone | Homo sapiens (human) | IC50 | 17.5500 | 2 | 2 |
psammaplin a | Homo sapiens (human) | IC50 | 0.7912 | 4 | 4 |
trichostatin c | Homo sapiens (human) | IC50 | 23.6300 | 1 | 1 |
laq824 | Homo sapiens (human) | IC50 | 0.0545 | 7 | 11 |
laq824 | Homo sapiens (human) | Ki | 0.0095 | 2 | 2 |
indigo carmine | Homo sapiens (human) | IC50 | 321.6200 | 2 | 2 |
tanespimycin | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
pd 404182 | Homo sapiens (human) | IC50 | 7.0000 | 1 | 1 |
tubacin | Homo sapiens (human) | IC50 | 0.4668 | 16 | 16 |
tubacin | Homo sapiens (human) | Ki | 1.2660 | 4 | 6 |
(3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone | Homo sapiens (human) | IC50 | 3.9045 | 14 | 14 |
(3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone | Homo sapiens (human) | Ki | 0.1234 | 1 | 1 |
belinostat | Homo sapiens (human) | IC50 | 3.9414 | 14 | 26 |
belinostat | Homo sapiens (human) | Ki | 0.0036 | 4 | 4 |
sk-7041 | Homo sapiens (human) | IC50 | 0.1720 | 1 | 1 |
panobinostat | Homo sapiens (human) | IC50 | 0.2307 | 22 | 30 |
panobinostat | Homo sapiens (human) | Ki | 0.0148 | 6 | 6 |
hdac-42 | Homo sapiens (human) | IC50 | 0.0113 | 2 | 2 |
4-acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | Homo sapiens (human) | IC50 | 8.1611 | 7 | 25 |
4-acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | Homo sapiens (human) | Ki | 0.1672 | 1 | 3 |
n1-(2-aminophenyl)-n7-phenylheptanediamide | Homo sapiens (human) | IC50 | 78.0000 | 1 | 1 |
bml 210 | Homo sapiens (human) | IC50 | 91.4000 | 5 | 5 |
n-(2-amino-5-fluorobenzyl)-4-(n-(pyridine-3-acrylyl)aminomethyl)benzamide | Homo sapiens (human) | IC50 | 146.3929 | 7 | 7 |
givinostat | Homo sapiens (human) | IC50 | 0.0982 | 4 | 4 |
givinostat | Homo sapiens (human) | Ki | 0.0042 | 2 | 2 |
mocetinostat | Homo sapiens (human) | IC50 | 8.6016 | 9 | 19 |
6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-n-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6s)- | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
methyl 3,5-di-o-caffeoyl quinate | Homo sapiens (human) | IC50 | 6.2900 | 2 | 2 |
r 306465 | Homo sapiens (human) | IC50 | 0.0360 | 2 | 2 |
di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
spiruchostatin a | Homo sapiens (human) | IC50 | 1.6000 | 1 | 1 |
quisinostat | Homo sapiens (human) | IC50 | 0.0664 | 4 | 4 |
quisinostat | Homo sapiens (human) | Ki | 0.1834 | 2 | 2 |
resminostat | Homo sapiens (human) | IC50 | 0.0720 | 2 | 2 |
abexinostat | Homo sapiens (human) | IC50 | 0.0120 | 1 | 1 |
abexinostat | Homo sapiens (human) | Ki | 0.0490 | 3 | 8 |
dactolisib | Homo sapiens (human) | IC50 | 0.0020 | 1 | 1 |
chidamide | Homo sapiens (human) | IC50 | 5.7890 | 3 | 2 |
hc toxin | Homo sapiens (human) | IC50 | 0.4300 | 1 | 1 |
hc toxin | Homo sapiens (human) | Ki | 0.3500 | 1 | 1 |
azumamide e | Homo sapiens (human) | IC50 | 31.0000 | 2 | 2 |
azumamide e | Homo sapiens (human) | Ki | 5.0000 | 1 | 1 |
cnf 2024 | Homo sapiens (human) | IC50 | 1.0000 | 2 | 2 |
N-(2-aminophenyl)-2-pyrazinecarboxamide | Homo sapiens (human) | IC50 | 11.7075 | 2 | 2 |
pci 34051 | Homo sapiens (human) | IC50 | 19.1592 | 13 | 13 |
cudc 101 | Homo sapiens (human) | IC50 | 0.1555 | 7 | 4 |
largazole | Homo sapiens (human) | IC50 | 4.2208 | 7 | 7 |
N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]-oxomethyl]-5-isoxazolyl]phenyl]carbamic acid tert-butyl ester | Homo sapiens (human) | IC50 | 0.0213 | 7 | 7 |
trichostatin rk | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
incb-018424 | Homo sapiens (human) | IC50 | 0.0150 | 1 | 1 |
jq1 compound | Homo sapiens (human) | IC50 | 0.2910 | 1 | 1 |
tubastatin a | Homo sapiens (human) | IC50 | 3.1766 | 72 | 81 |
tubastatin a | Homo sapiens (human) | Ki | 0.0057 | 5 | 5 |
pracinostat | Homo sapiens (human) | IC50 | 0.1095 | 2 | 2 |
pracinostat | Homo sapiens (human) | Ki | 0.2470 | 1 | 1 |
acy-1215 | Homo sapiens (human) | IC50 | 0.0840 | 34 | 34 |
acy-1215 | Homo sapiens (human) | Ki | 0.0010 | 1 | 1 |
cudc-907 | Homo sapiens (human) | IC50 | 0.1039 | 8 | 8 |
rgfp966 | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
mi-192 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
acy-738 | Homo sapiens (human) | IC50 | 0.0018 | 8 | 8 |
2-((1-(3-fluorophenyl)cyclohexyl)amino)-n-hydroxypyrimidine-5-carboxamide | Homo sapiens (human) | IC50 | 0.0075 | 4 | 4 |
4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide | Homo sapiens (human) | IC50 | 0.1536 | 15 | 15 |
4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide | Homo sapiens (human) | Ki | 0.0300 | 1 | 1 |
osimertinib | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
santacruzamate a | Homo sapiens (human) | IC50 | 1.9555 | 2 | 3 |
Drugs with Activation Measurements
Drugs with Other Measurements
Effect of Inhibiting Histone Deacetylase with Short-Chain Carboxylic Acids and Their Hydroxamic Acid Analogs on Vertebrate Development and Neuronal Chromatin.ACS medicinal chemistry letters, , Oct-08, Volume: 2, Issue:1, 2010
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.Bioorganic & medicinal chemistry, , Jul-15, Volume: 17, Issue:14, 2009
Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling.ACS medicinal chemistry letters, , Jun-13, Volume: 10, Issue:6, 2019
Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.European journal of medicinal chemistry, , Jul-01, Volume: 173, 2019
Thioether-based 2-aminobenzamide derivatives: Novel HDAC inhibitors with potent in vitro and in vivo antitumor activity.European journal of medicinal chemistry, , Aug-15, Volume: 176, 2019
Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents.European journal of medicinal chemistry, , Jan-01, Volume: 143, 2018
Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents.European journal of medicinal chemistry, , Jul-07, Volume: 134, 2017
An Isochemogenic Set of Inhibitors To Define the Therapeutic Potential of Histone Deacetylases in β-Cell Protection.ACS chemical biology, , Feb-19, Volume: 11, Issue:2, 2016
Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 26, Issue:1, 2016
Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity.Journal of medicinal chemistry, , Nov-15, Volume: 50, Issue:23, 2007
From natural products to HDAC inhibitors: An overview of drug discovery and design strategy.Bioorganic & medicinal chemistry, , 12-15, Volume: 52, 2021
A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles.European journal of medicinal chemistry, , Oct-15, Volume: 222, 2021
Effect of Inhibiting Histone Deacetylase with Short-Chain Carboxylic Acids and Their Hydroxamic Acid Analogs on Vertebrate Development and Neuronal Chromatin.ACS medicinal chemistry letters, , Oct-08, Volume: 2, Issue:1, 2010
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.Bioorganic & medicinal chemistry, , Jul-15, Volume: 17, Issue:14, 2009
New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 18, Issue:6, 2008
Development and Therapeutic Potential of Selenazo Compounds.Journal of medicinal chemistry, , 02-27, Volume: 63, Issue:4, 2020
Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer's disease.Bioorganic & medicinal chemistry, , 11-15, Volume: 26, Issue:21, 2018
Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs).Bioorganic & medicinal chemistry, , Feb-15, Volume: 16, Issue:4, 2008
Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates.Journal of medicinal chemistry, , Feb-14, Volume: 45, Issue:4, 2002
Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cells.European journal of medicinal chemistry, , Apr-15, Volume: 234, 2022
Synthesis and biological evaluation of aminobenzamides containing purine moiety as class I histone deacetylases inhibitors.Bioorganic & medicinal chemistry, , 02-15, Volume: 56, 2022
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.Journal of medicinal chemistry, , 02-24, Volume: 65, Issue:4, 2022
Discovery of Novel Src Homology-2 Domain-Containing Phosphatase 2 and Histone Deacetylase Dual Inhibitors with Potent Antitumor Efficacy and Enhanced Antitumor Immunity.Journal of medicinal chemistry, , 09-22, Volume: 65, Issue:18, 2022
Discovery of a Novel G-Quadruplex and Histone Deacetylase (HDAC) Dual-Targeting Agent for the Treatment of Triple-Negative Breast Cancer.Journal of medicinal chemistry, , 09-22, Volume: 65, Issue:18, 2022
Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes.European journal of medicinal chemistry, , Jan-01, Volume: 209, 2021
[no title available]Journal of medicinal chemistry, , 06-24, Volume: 64, Issue:12, 2021
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
[no title available]European journal of medicinal chemistry, , Jun-15, Volume: 196, 2020
Synthesis of Peptoid-Based Class I-Selective Histone Deacetylase Inhibitors with Chemosensitizing Properties.Journal of medicinal chemistry, , 12-26, Volume: 62, Issue:24, 2019
Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.European journal of medicinal chemistry, , Jul-01, Volume: 173, 2019
1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase.European journal of medicinal chemistry, , Jan-15, Volume: 162, 2019
Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents.European journal of medicinal chemistry, , Jan-01, Volume: 143, 2018
Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously.Journal of medicinal chemistry, , 06-28, Volume: 61, Issue:12, 2018
4-Indolyl-N-hydroxyphenylacrylamides as potent HDAC class I and IIB inhibitors in vitro and in vivo.European journal of medicinal chemistry, , Jul-07, Volume: 134, 2017
Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.Journal of medicinal chemistry, , Feb-25, Volume: 59, Issue:4, 2016
Identification of new quinic acid derivatives as histone deacetylase inhibitors by fluorescence-based cellular assay.Bioorganic & medicinal chemistry letters, , May-01, Volume: 26, Issue:9, 2016
Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity.European journal of medicinal chemistry, , Jun-30, Volume: 116, 2016
Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2).Bioorganic & medicinal chemistry, , Sep-01, Volume: 21, Issue:17, 2013
Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability.The Journal of biological chemistry, , Sep-13, Volume: 288, Issue:37, 2013
Appraisal of GABA and PABA as linker: design and synthesis of novel benzamide based histone deacetylase inhibitors.European journal of medicinal chemistry, , Volume: 53, 2012
The structural requirements of histone deacetylase inhibitors: suberoylanilide hydroxamic acid analogs modified at the C6 position.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 22, Issue:23, 2012
The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 21, Issue:20, 2011
On the inhibition of histone deacetylase 8.Bioorganic & medicinal chemistry, , Jun-01, Volume: 18, Issue:11, 2010
Inhibitors selective for HDAC6 in enzymes and cells.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 20, Issue:23, 2010
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.Nature chemical biology, , Volume: 6, Issue:1, 2010
Recent advances in the development of polyamine analogues as antitumor agents.Journal of medicinal chemistry, , Aug-13, Volume: 52, Issue:15, 2009
Discovery of a potent class I selective ketone histone deacetylase inhibitor with antitumor activity in vivo and optimized pharmacokinetic properties.Journal of medicinal chemistry, , Jun-11, Volume: 52, Issue:11, 2009
A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo.Journal of medicinal chemistry, , Apr-24, Volume: 51, Issue:8, 2008
Optimization of biaryl Selective HDAC1&2 Inhibitors (SHI-1:2).Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 18, Issue:2, 2008
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 18, Issue:6, 2008
Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agents.Bioorganic & medicinal chemistry, , Sep-01, Volume: 16, Issue:17, 2008
Histone deacetylase inhibitors: from bench to clinic.Journal of medicinal chemistry, , Mar-27, Volume: 51, Issue:6, 2008
Structural requirements of HDAC inhibitors: SAHA analogs functionalized adjacent to the hydroxamic acid.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 17, Issue:8, 2007
Trithiocarbonates: exploration of a new head group for HDAC inhibitors.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 17, Issue:17, 2007
(2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Jan-05, Volume: 14, Issue:1, 2004
Histone deacetylase inhibitors.Journal of medicinal chemistry, , Nov-20, Volume: 46, Issue:24, 2003
Heterocyclic ketones as inhibitors of histone deacetylase.Bioorganic & medicinal chemistry letters, , Nov-17, Volume: 13, Issue:22, 2003
Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives.Journal of medicinal chemistry, , Jul-29, Volume: 42, Issue:15, 1999
[no title available],
Effect of Inhibiting Histone Deacetylase with Short-Chain Carboxylic Acids and Their Hydroxamic Acid Analogs on Vertebrate Development and Neuronal Chromatin.ACS medicinal chemistry letters, , Oct-08, Volume: 2, Issue:1, 2010
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.Bioorganic & medicinal chemistry, , Jul-15, Volume: 17, Issue:14, 2009
Highly fluorescent and HDAC6 selective scriptaid analogues.European journal of medicinal chemistry, , Jan-15, Volume: 162, 2019
Novel Polyamine-Naphthalene Diimide Conjugates Targeting Histone Deacetylases and DNA for Cancer Phenotype Reprogramming.ACS medicinal chemistry letters, , Dec-14, Volume: 8, Issue:12, 2017
Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy.Bioorganic & medicinal chemistry, , 04-01, Volume: 25, Issue:7, 2017
Chemical phylogenetics of histone deacetylases.Nature chemical biology, , Volume: 6, Issue:3, 2010
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.Nature chemical biology, , Volume: 6, Issue:1, 2010
Discovery of HDAC6-Selective Inhibitor NN-390 with Journal of medicinal chemistry, , 02-24, Volume: 65, Issue:4, 2022
Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic Activity.Journal of medicinal chemistry, , 12-22, Volume: 65, Issue:24, 2022
Design, synthesis, and biological evaluation of β-carboline 1,3,4-oxadiazole based hybrids as HDAC inhibitors with potential antitumor effects.Bioorganic & medicinal chemistry letters, , 05-15, Volume: 64, 2022
Design, synthesis and biological evaluation of novel pyrazinone derivatives as PI3K/HDAC dual inhibitors.Bioorganic & medicinal chemistry, , Nov-15, Volume: 74, 2022
Discovery of phthalazino[1,2-b]-quinazolinone derivatives as multi-target HDAC inhibitors for the treatment of hepatocellular carcinoma via activating the p53 signal pathway.European journal of medicinal chemistry, , Feb-05, Volume: 229, 2022
Identification of PI3K/HDAC Dual-targeted inhibitors with subtype selectivity as potential therapeutic agents against solid Tumors: Building HDAC6 potency in a Quinazolinone-based PI3Kδ-selective template.Bioorganic & medicinal chemistry, , 11-01, Volume: 73, 2022
[no title available]Journal of medicinal chemistry, , 12-22, Volume: 65, Issue:24, 2022
Novel biphenyl-based scaffold as potent and selective histone deacetylase 6 (HDAC6) inhibitors: Identification, development and pharmacological evaluation.European journal of medicinal chemistry, , Apr-05, Volume: 233, 2022
[no title available]Bioorganic & medicinal chemistry, , 01-01, Volume: 53, 2022
Discovery of a Novel Vascular Disrupting Agent Inhibiting Tubulin Polymerization and HDACs with Potent Antitumor Effects.Journal of medicinal chemistry, , 08-25, Volume: 65, Issue:16, 2022
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.Journal of medicinal chemistry, , 02-24, Volume: 65, Issue:4, 2022
Discovery of Novel Src Homology-2 Domain-Containing Phosphatase 2 and Histone Deacetylase Dual Inhibitors with Potent Antitumor Efficacy and Enhanced Antitumor Immunity.Journal of medicinal chemistry, , 09-22, Volume: 65, Issue:18, 2022
Accommodation of ring C expanded deoxyvasicinone in the HDAC inhibitory pharmacophore culminates into a tractable anti-lung cancer agent and pH-responsive nanocarrier.European journal of medicinal chemistry, , Oct-05, Volume: 240, 2022
Design, synthesis, and biological evalution of bifunctional inhibitors against Hsp90-HDAC6 interplay.European journal of medicinal chemistry, , Oct-05, Volume: 240, 2022
Histone Deacetylase and Enhancer of Zeste Homologue 2 Dual Inhibitors Presenting a Synergistic Effect for the Treatment of Hematological Malignancies.Journal of medicinal chemistry, , 10-13, Volume: 65, Issue:19, 2022
First-in-Class Dual Mechanism Ferroptosis-HDAC Inhibitor Hybrids.Journal of medicinal chemistry, , 11-10, Volume: 65, Issue:21, 2022
Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity.Journal of medicinal chemistry, , 02-24, Volume: 65, Issue:4, 2022
[no title available]Journal of medicinal chemistry, , 01-27, Volume: 65, Issue:2, 2022
Synthesis and biological evaluation of aminobenzamides containing purine moiety as class I histone deacetylases inhibitors.Bioorganic & medicinal chemistry, , 02-15, Volume: 56, 2022
Novel PHD2/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury.European journal of medicinal chemistry, , Feb-15, Volume: 230, 2022
Heat shock protein 90 (Hsp90)/Histone deacetylase (HDAC) dual inhibitors for the treatment of azoles-resistant Candida albicans.European journal of medicinal chemistry, , Jan-05, Volume: 227, 2022
Design, synthesis, and biological evaluation of indole-based hydroxamic acid derivatives as histone deacetylase inhibitors.European journal of medicinal chemistry, , Jan-05, Volume: 227, 2022
Comparison of three zinc binding groups for HDAC inhibitors - A potency, selectivity and enzymatic kinetics study.Bioorganic & medicinal chemistry letters, , 08-15, Volume: 70, 2022
Discovery of a Novel G-Quadruplex and Histone Deacetylase (HDAC) Dual-Targeting Agent for the Treatment of Triple-Negative Breast Cancer.Journal of medicinal chemistry, , 09-22, Volume: 65, Issue:18, 2022
Exploration of 4-(1H-indol-3-yl)cyclohex-3-en-1-amine analogues as HDAC inhibitors: Design, synthesis, biological evaluation and modelling studies.Bioorganic & medicinal chemistry letters, , 09-15, Volume: 72, 2022
Design, synthesis and antitumor activity study of PARP-1/HDAC dual targeting inhibitors.Bioorganic & medicinal chemistry letters, , 09-01, Volume: 71, 2022
Discovery of 2,5-diphenyl-1,3,4-thiadiazole derivatives as HDAC inhibitors with DNA binding affinity.European journal of medicinal chemistry, , Nov-05, Volume: 241, 2022
Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia.Journal of medicinal chemistry, , 11-24, Volume: 65, Issue:22, 2022
[no title available]Journal of medicinal chemistry, , 03-10, Volume: 65, Issue:5, 2022
[no title available]Journal of medicinal chemistry, , 02-10, Volume: 65, Issue:3, 2022
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype.Journal of medicinal chemistry, , 03-11, Volume: 64, Issue:5, 2021
Procainamide-SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites.Journal of medicinal chemistry, , 07-22, Volume: 64, Issue:14, 2021
[no title available]Journal of medicinal chemistry, , 11-25, Volume: 64, Issue:22, 2021
Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010-2020).European journal of medicinal chemistry, , Dec-15, Volume: 226, 2021
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia.Journal of medicinal chemistry, , 06-24, Volume: 64, Issue:12, 2021
From natural products to HDAC inhibitors: An overview of drug discovery and design strategy.Bioorganic & medicinal chemistry, , 12-15, Volume: 52, 2021
Cysteine derivatives as acetyl lysine mimics to inhibit zinc-dependent histone deacetylases for treating cancer.European journal of medicinal chemistry, , Dec-05, Volume: 225, 2021
Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis.European journal of medicinal chemistry, , Dec-05, Volume: 225, 2021
Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency.European journal of medicinal chemistry, , Dec-05, Volume: 225, 2021
Identification of novel 1,3-diaryl-1,2,4-triazole-capped histone deacetylase 6 inhibitors with potential anti-gastric cancer activity.European journal of medicinal chemistry, , Jun-05, Volume: 218, 2021
Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma.European journal of medicinal chemistry, , Dec-05, Volume: 225, 2021
Novel dual-mode antitumor chlorin-based derivatives as potent photosensitizers and histone deacetylase inhibitors for photodynamic therapy and chemotherapy.European journal of medicinal chemistry, , May-05, Volume: 217, 2021
Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis.Journal of medicinal chemistry, , 01-28, Volume: 64, Issue:2, 2021
Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors.European journal of medicinal chemistry, , Oct-05, Volume: 221, 2021
Discovery of 2,4-pyrimidinediamine derivatives as potent dual inhibitors of ALK and HDAC.European journal of medicinal chemistry, , Nov-15, Volume: 224, 2021
Novel hybrid conjugates with dual estrogen receptor α degradation and histone deacetylase inhibitory activities for breast cancer therapy.Bioorganic & medicinal chemistry, , 06-15, Volume: 40, 2021
Discovery of novel pyrazolopyrimidine derivatives as potent mTOR/HDAC bi-functional inhibitors via pharmacophore-merging strategy.Bioorganic & medicinal chemistry letters, , 10-01, Volume: 49, 2021
Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes.European journal of medicinal chemistry, , Jan-01, Volume: 209, 2021
Intracellular fluorescence competition assay for inhibitor engagement of histone deacetylase.Bioorganic & medicinal chemistry letters, , 09-01, Volume: 47, 2021
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with Journal of medicinal chemistry, , 03-25, Volume: 64, Issue:6, 2021
Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors.European journal of medicinal chemistry, , Feb-05, Volume: 211, 2021
Synthesis and biological evaluation of phenothiazine derivative-containing hydroxamic acids as potent class II histone deacetylase inhibitors.European journal of medicinal chemistry, , Jul-05, Volume: 219, 2021
[no title available]Journal of medicinal chemistry, , 10-28, Volume: 64, Issue:20, 2021
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model.Journal of medicinal chemistry, , 04-22, Volume: 64, Issue:8, 2021
Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction.European journal of medicinal chemistry, , Jun-05, Volume: 218, 2021
A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles.European journal of medicinal chemistry, , Oct-15, Volume: 222, 2021
[no title available]European journal of medicinal chemistry, , Feb-05, Volume: 211, 2021
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.European journal of medicinal chemistry, , Jan-01, Volume: 209, 2021
2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents.European journal of medicinal chemistry, , Jan-15, Volume: 210, 2021
Current status in the discovery of dual BET/HDAC inhibitors.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 38, 2021
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer's Disease Multitarget Drug Discovery?Journal of medicinal chemistry, , 01-14, Volume: 64, Issue:1, 2021
4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug Leads.Journal of medicinal chemistry, , 10-14, Volume: 64, Issue:19, 2021
Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer.European journal of medicinal chemistry, , Aug-05, Volume: 220, 2021
Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer.European journal of medicinal chemistry, , Dec-15, Volume: 226, 2021
Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease.European journal of medicinal chemistry, , Apr-15, Volume: 192, 2020
Design, synthesis and biological evaluation of novel HDAC inhibitors with improved pharmacokinetic profile in breast cancer.European journal of medicinal chemistry, , Nov-01, Volume: 205, 2020
A 18β-glycyrrhetinic acid conjugate with Vorinostat degrades HDAC3 and HDAC6 with improved antitumor effects.European journal of medicinal chemistry, , Feb-15, Volume: 188, 2020
Pyrimethamine conjugated histone deacetylase inhibitors: Design, synthesis and evidence for triple negative breast cancer selective cytotoxicity.Bioorganic & medicinal chemistry, , 03-15, Volume: 28, Issue:6, 2020
Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer Cells.ACS medicinal chemistry letters, , May-14, Volume: 11, Issue:5, 2020
Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity.Journal of medicinal chemistry, , 05-28, Volume: 63, Issue:10, 2020
Discovery of Thieno[2,3-Journal of medicinal chemistry, , 04-09, Volume: 63, Issue:7, 2020
Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups.Journal of medicinal chemistry, , 09-24, Volume: 63, Issue:18, 2020
The design of a novel near-infrared fluorescent HDAC inhibitor and image of tumor cells.Bioorganic & medicinal chemistry, , 09-01, Volume: 28, Issue:17, 2020
Dual-Target Inhibitors Based on HDACs: Novel Antitumor Agents for Cancer Therapy.Journal of medicinal chemistry, , 09-10, Volume: 63, Issue:17, 2020
Environment-sensitive fluorescent inhibitors of histone deacetylase.Bioorganic & medicinal chemistry letters, , 06-01, Volume: 30, Issue:11, 2020
Novel alkoxyamide-based histone deacetylase inhibitors reverse cisplatin resistance in chemoresistant cancer cells.Bioorganic & medicinal chemistry, , 01-01, Volume: 28, Issue:1, 2020
Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis.Journal of medicinal chemistry, , 05-28, Volume: 63, Issue:10, 2020
[no title available]Journal of medicinal chemistry, , 05-14, Volume: 63, Issue:9, 2020
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.Journal of medicinal chemistry, , 01-09, Volume: 63, Issue:1, 2020
Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells.Bioorganic & medicinal chemistry letters, , 12-15, Volume: 30, Issue:24, 2020
Design, synthesis and evaluation of novel indirubin-based N-hydroxybenzamides, N-hydroxypropenamides and N-hydroxyheptanamides as histone deacetylase inhibitors and antitumor agents.Bioorganic & medicinal chemistry letters, , 11-15, Volume: 30, Issue:22, 2020
Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo.European journal of medicinal chemistry, , Mar-15, Volume: 190, 2020
Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.Journal of medicinal chemistry, , 07-09, Volume: 63, Issue:13, 2020
Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia.ACS medicinal chemistry letters, , Jan-09, Volume: 11, Issue:1, 2020
N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression.European journal of medicinal chemistry, , Jan-01, Volume: 185, 2020
HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells.Journal of medicinal chemistry, , 10-22, Volume: 63, Issue:20, 2020
Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.Bioorganic & medicinal chemistry letters, , 04-15, Volume: 30, Issue:8, 2020
New Dual CK2/HDAC1 Inhibitors with Nanomolar Inhibitory Activity against Both Enzymes.ACS medicinal chemistry letters, , May-14, Volume: 11, Issue:5, 2020
Design, synthesis and activity evaluation of indole-based double - Branched HDAC1 inhibitors.Bioorganic & medicinal chemistry, , 04-15, Volume: 27, Issue:8, 2019
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease.ACS medicinal chemistry letters, , Apr-11, Volume: 10, Issue:4, 2019
[no title available]Journal of medicinal chemistry, , 02-14, Volume: 62, Issue:3, 2019
Fluorescent analogs of peptoid-based HDAC inhibitors: Synthesis, biological activity and cellular uptake kinetics.Bioorganic & medicinal chemistry, , 10-01, Volume: 27, Issue:19, 2019
Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling.ACS medicinal chemistry letters, , Jun-13, Volume: 10, Issue:6, 2019
Structure-activity relationship study of thiazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.Bioorganic & medicinal chemistry, , 08-01, Volume: 27, Issue:15, 2019
Discovery of 1,2,4-oxadiazole-Containing hydroxamic acid derivatives as histone deacetylase inhibitors potential application in cancer therapy.European journal of medicinal chemistry, , Sep-15, Volume: 178, 2019
A fluorine scan on the ZnEuropean journal of medicinal chemistry, , Nov-15, Volume: 182, 2019
Design, synthesis, and bioactivity evaluation of novel Bcl-2/HDAC dual-target inhibitors for the treatment of multiple myeloma.Bioorganic & medicinal chemistry letters, , 02-01, Volume: 29, Issue:3, 2019
Fluorinated Analogues of the Histone Deacetylase Inhibitor Vorinostat (Zolinza): Validation of a Chiral Hybrid Bioisostere, BITE.ACS medicinal chemistry letters, , Sep-12, Volume: 10, Issue:9, 2019
A novel class of anthraquinone-based HDAC6 inhibitors.European journal of medicinal chemistry, , Feb-15, Volume: 164, 2019
Design, synthesis, and biological evaluation of a new class of histone acetyltransferase p300 inhibitors.European journal of medicinal chemistry, , Oct-15, Volume: 180, 2019
Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.Journal of medicinal chemistry, , 02-14, Volume: 62, Issue:3, 2019
β-Carboline and N-hydroxycinnamamide hybrids as anticancer agents for drug-resistant hepatocellular carcinoma.European journal of medicinal chemistry, , Apr-15, Volume: 168, 2019
Design, synthesis and biological evaluation of β-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activity.MedChemComm, , Jul-01, Volume: 10, Issue:7, 2019
Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor.European journal of medicinal chemistry, , Dec-15, Volume: 184, 2019
Novel α,β-unsaturated hydroxamic acid derivatives overcome cisplatin resistance.Bioorganic & medicinal chemistry, , 10-01, Volume: 27, Issue:19, 2019
Hydroxamic Acid Derivatives of β-Carboline/Hydroxycinnamic Acid Hybrids Inducing Apoptosis and Autophagy through the PI3K/Akt/mTOR Pathways.Journal of natural products, , 06-28, Volume: 82, Issue:6, 2019
Indole: A privileged scaffold for the design of anti-cancer agents.European journal of medicinal chemistry, , Dec-01, Volume: 183, 2019
Anti-tumor activity evaluation of novel tubulin and HDAC dual-targeting inhibitors.Bioorganic & medicinal chemistry letters, , 09-15, Volume: 29, Issue:18, 2019
Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models.Journal of medicinal chemistry, , 09-26, Volume: 62, Issue:18, 2019
Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies.Journal of medicinal chemistry, , 04-25, Volume: 62, Issue:8, 2019
Synthesis of Peptoid-Based Class I-Selective Histone Deacetylase Inhibitors with Chemosensitizing Properties.Journal of medicinal chemistry, , 12-26, Volume: 62, Issue:24, 2019
Design, Synthesis, and Biological Evaluation of 2,4-Imidazolinedione Derivatives as HDAC6 Isoform-Selective Inhibitors.ACS medicinal chemistry letters, , Aug-08, Volume: 10, Issue:8, 2019
Design and synthesis of potent dual inhibitors of JAK2 and HDAC based on fusing the pharmacophores of XL019 and vorinostat.European journal of medicinal chemistry, , Oct-05, Volume: 158, 2018
Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents.European journal of medicinal chemistry, , Jan-01, Volume: 143, 2018
Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery.ACS medicinal chemistry letters, , Jan-11, Volume: 9, Issue:1, 2018
Discovery of aliphatic-chain hydroxamates containing indole derivatives with potent class I histone deacetylase inhibitory activities.European journal of medicinal chemistry, , Jan-01, Volume: 143, 2018
Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma.Journal of medicinal chemistry, , 02-22, Volume: 61, Issue:4, 2018
Molecular Basis for the Selective Inhibition of Histone Deacetylase 6 by a Mercaptoacetamide Inhibitor.ACS medicinal chemistry letters, , Dec-13, Volume: 9, Issue:12, 2018
Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer's disease.Bioorganic & medicinal chemistry, , 11-15, Volume: 26, Issue:21, 2018
Design and synthesis of triple inhibitors of janus kinase (JAK), histone deacetylase (HDAC) and Heat Shock Protein 90 (HSP90).Bioorganic & medicinal chemistry letters, , 05-01, Volume: 28, Issue:8, 2018
Small Molecules Simultaneously Inhibiting p53-Murine Double Minute 2 (MDM2) Interaction and Histone Deacetylases (HDACs): Discovery of Novel Multitargeting Antitumor Agents.Journal of medicinal chemistry, , 08-23, Volume: 61, Issue:16, 2018
Incorporation of histone deacetylase inhibitory activity into the core of tamoxifen - A new hybrid design paradigm.Bioorganic & medicinal chemistry, , 08-15, Volume: 26, Issue:15, 2018
Structure optimization and preliminary bioactivity evaluation of N-hydroxybenzamide-based HDAC inhibitors with Y-shaped cap.Bioorganic & medicinal chemistry, , 05-01, Volume: 26, Issue:8, 2018
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease.European journal of medicinal chemistry, , Apr-25, Volume: 150, 2018
Design, synthesis and evaluate of novel dual FGFR1 and HDAC inhibitors bearing an indazole scaffold.Bioorganic & medicinal chemistry, , 02-01, Volume: 26, Issue:3, 2018
Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells.European journal of medicinal chemistry, , Jan-20, Volume: 144, 2018
The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.European journal of medicinal chemistry, , Jan-01, Volume: 143, 2018
Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors.European journal of medicinal chemistry, , Apr-25, Volume: 150, 2018
Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously.Journal of medicinal chemistry, , 06-28, Volume: 61, Issue:12, 2018
HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors.European journal of medicinal chemistry, , Oct-05, Volume: 158, 2018
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.European journal of medicinal chemistry, , Oct-05, Volume: 158, 2018
Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors.ACS medicinal chemistry letters, , Feb-08, Volume: 9, Issue:2, 2018
A series of camptothecin prodrugs exhibit HDAC inhibition activity.Bioorganic & medicinal chemistry, , 09-01, Volume: 26, Issue:16, 2018
Spirohydantoins and 1,2,4-triazole-3-carboxamide derivatives as inhibitors of histone deacetylase: Design, synthesis, and biological evaluation.European journal of medicinal chemistry, , Feb-25, Volume: 146, 2018
Histone Deacetylase Inhibitors as Treatment for Targeting Multiple Components in Cancer Therapy.ACS medicinal chemistry letters, , Mar-08, Volume: 9, Issue:3, 2018
Design, synthesis and anticancer evaluation of acridine hydroxamic acid derivatives as dual Topo and HDAC inhibitors.Bioorganic & medicinal chemistry, , 08-07, Volume: 26, Issue:14, 2018
1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC.European journal of medicinal chemistry, , Apr-25, Volume: 150, 2018
Design, synthesis and biological evaluation of novel hydroxamic acid based histone deacetylase 6 selective inhibitors bearing phenylpyrazol scaffold as surface recognition motif.Bioorganic & medicinal chemistry, , 05-01, Volume: 26, Issue:8, 2018
LSD1 Substrate Binding and Gene Expression Are Affected by HDAC1-Mediated Deacetylation.ACS chemical biology, , 01-20, Volume: 12, Issue:1, 2017
Design, synthesis, and preliminary bioactivity evaluation of NChemical biology & drug design, , Volume: 89, Issue:1, 2017
The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity.Bioorganic & medicinal chemistry letters, , 08-01, Volume: 27, Issue:15, 2017
Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors.European journal of medicinal chemistry, , Jun-16, Volume: 133, 2017
4-Indolyl-N-hydroxyphenylacrylamides as potent HDAC class I and IIB inhibitors in vitro and in vivo.European journal of medicinal chemistry, , Jul-07, Volume: 134, 2017
3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity.European journal of medicinal chemistry, , Jan-05, Volume: 125, 2017
Design, synthesis and biological evaluation of novel histone deacetylase inhibitors incorporating 4-aminoquinazolinyl systems as capping groups.Bioorganic & medicinal chemistry letters, , 11-01, Volume: 27, Issue:21, 2017
Structural Requirements of HDAC Inhibitors: SAHA Analogues Modified at the C2 Position Display HDAC6/8 Selectivity.ACS medicinal chemistry letters, , Mar-09, Volume: 8, Issue:3, 2017
Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell Lines.Journal of medicinal chemistry, , 07-13, Volume: 60, Issue:13, 2017
Design, synthesis and evaluation of antiproliferative activity of melanoma-targeted histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , 02-15, Volume: 27, Issue:4, 2017
Synthesis and Pharmacological Evaluation of Selective Histone Deacetylase 6 Inhibitors in Melanoma Models.ACS medicinal chemistry letters, , Oct-12, Volume: 8, Issue:10, 2017
Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors.Journal of medicinal chemistry, , 10-12, Volume: 60, Issue:19, 2017
Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap Groups.Journal of medicinal chemistry, , 07-13, Volume: 60, Issue:13, 2017
Synthesis and investigation of novel 6-(1,2,3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapy.Bioorganic & medicinal chemistry, , 01-01, Volume: 25, Issue:1, 2017
Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities.MedChemComm, , Jun-01, Volume: 8, Issue:6, 2017
Olaparib hydroxamic acid derivatives as dual PARP and HDAC inhibitors for cancer therapy.Bioorganic & medicinal chemistry, , 08-01, Volume: 25, Issue:15, 2017
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat.Journal of medicinal chemistry, , 10-26, Volume: 60, Issue:20, 2017
Design, synthesis and anticancer potential of NSC-319745 hydroxamic acid derivatives as DNMT and HDAC inhibitors.European journal of medicinal chemistry, , Jul-07, Volume: 134, 2017
Design, synthesis and biological evaluation of thienopyrimidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors.European journal of medicinal chemistry, , Mar-10, Volume: 128, 2017
Discovery of a fluorescent probe with HDAC6 selective inhibition.European journal of medicinal chemistry, , Dec-01, Volume: 141, 2017
Cyclic tetrapeptide HDAC inhibitors as potential therapeutics for spinal muscular atrophy: Screening with iPSC-derived neuronal cells.Bioorganic & medicinal chemistry letters, , 08-01, Volume: 27, Issue:15, 2017
Rational design, synthesis and preliminary antitumor activity evaluation of a chlorambucil derivative with potent DNA/HDAC dual-targeting inhibitory activity.Bioorganic & medicinal chemistry letters, , 09-15, Volume: 27, Issue:18, 2017
An Isochemogenic Set of Inhibitors To Define the Therapeutic Potential of Histone Deacetylases in β-Cell Protection.ACS chemical biology, , Feb-19, Volume: 11, Issue:2, 2016
Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors.Bioorganic & medicinal chemistry letters, , 06-15, Volume: 26, Issue:12, 2016
Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy.European journal of medicinal chemistry, , Apr-13, Volume: 112, 2016
Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease.Journal of medicinal chemistry, , 10-13, Volume: 59, Issue:19, 2016
Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazoline as the Cap for the Treatment of Cancer.Journal of medicinal chemistry, , Feb-25, Volume: 59, Issue:4, 2016
Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis.Journal of medicinal chemistry, , Mar-24, Volume: 59, Issue:6, 2016
Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC.European journal of medicinal chemistry, , Feb-15, Volume: 109, 2016
Novel thiol-based histone deacetylase inhibitors bearing 3-phenyl-1H-pyrazole-5-carboxamide scaffold as surface recognition motif: Design, synthesis and SAR study.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 26, Issue:2, 2016
Design and Synthesis of Janus Kinase 2 (JAK2) and Histone Deacetlyase (HDAC) Bispecific Inhibitors Based on Pacritinib and Evidence of Dual Pathway Inhibition in Hematological Cell Lines.Journal of medicinal chemistry, , Sep-22, Volume: 59, Issue:18, 2016
Biphenyl-4-yl-acrylohydroxamic acids: Identification of a novel indolyl-substituted HDAC inhibitor with antitumor activity.European journal of medicinal chemistry, , Apr-13, Volume: 112, 2016
Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.Journal of medicinal chemistry, , Feb-25, Volume: 59, Issue:4, 2016
Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts.European journal of medicinal chemistry, , Jan-27, Volume: 108, 2016
Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors.Journal of medicinal chemistry, , Feb-25, Volume: 59, Issue:4, 2016
Identification of N-(6-mercaptohexyl)-3-(4-pyridyl)-1H-pyrazole-5-carboxamide and its disulfide prodrug as potent histone deacetylase inhibitors with in vitro and in vivo anti-tumor efficacy.European journal of medicinal chemistry, , Feb-15, Volume: 109, 2016
Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 26, Issue:1, 2016
2-(Phenylsulfonyl)quinoline N-hydroxyacrylamides as potent anticancer agents inhibiting histone deacetylase.European journal of medicinal chemistry, , Oct-21, Volume: 122, 2016
Development of Purine-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities.Journal of medicinal chemistry, , 06-09, Volume: 59, Issue:11, 2016
Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors.European journal of medicinal chemistry, , Jan-27, Volume: 108, 2016
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition.Nature chemical biology, , Volume: 12, Issue:9, 2016
Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 25, Issue:22, 2015
Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 25, Issue:3, 2015
Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity.European journal of medicinal chemistry, , Jan-07, Volume: 89, 2015
Discovery of Novel Class I Histone Deacetylase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities.Journal of medicinal chemistry, , Oct-08, Volume: 58, Issue:19, 2015
Design, synthesis and preliminary biological evaluation of indoline-2,3-dione derivatives as novel HDAC inhibitors.Bioorganic & medicinal chemistry, , Aug-01, Volume: 23, Issue:15, 2015
Investigation on the ZBG-functionality of phenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 25, Issue:20, 2015
Discovery of 1-hydroxypyridine-2-thiones as selective histone deacetylase inhibitors and their potential application for treating leukemia.Bioorganic & medicinal chemistry letters, , Oct-01, Volume: 25, Issue:19, 2015
Novel Bioactive Hybrid Compound Dual Targeting Estrogen Receptor and Histone Deacetylase for the Treatment of Breast Cancer.Journal of medicinal chemistry, , Jun-11, Volume: 58, Issue:11, 2015
Dual-Mode HDAC Prodrug for Covalent Modification and Subsequent Inhibitor Release.Journal of medicinal chemistry, , Jun-11, Volume: 58, Issue:11, 2015
Macrocyclic compounds as anti-cancer agents: design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2.European journal of medicinal chemistry, , May-05, Volume: 95, 2015
Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors.ACS medicinal chemistry letters, , Mar-12, Volume: 6, Issue:3, 2015
Design, synthesis and evaluation of antiestrogen and histone deacetylase inhibitor molecular hybrids.Bioorganic & medicinal chemistry, , Dec-15, Volume: 23, Issue:24, 2015
Design, synthesis, and antitumor evaluation of novel histone deacetylase inhibitors equipped with a phenylsulfonylfuroxan module as a nitric oxide donor.Journal of medicinal chemistry, , May-28, Volume: 58, Issue:10, 2015
Design and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acids.European journal of medicinal chemistry, , Volume: 96, 2015
Design, synthesis and biological evaluation of isoquinoline-based derivatives as novel histone deacetylase inhibitors.Bioorganic & medicinal chemistry, , Sep-01, Volume: 23, Issue:17, 2015
Discovery of Orally Available Runt-Related Transcription Factor 3 (RUNX3) Modulators for Anticancer Chemotherapy by Epigenetic Activation and Protein Stabilization.Journal of medicinal chemistry, , Apr-23, Volume: 58, Issue:8, 2015
Design and synthesis of orally bioavailable aminopyrrolidinone histone deacetylase 6 inhibitors.Journal of medicinal chemistry, , Mar-26, Volume: 58, Issue:6, 2015
Novel β-Carboline/Hydroxamic Acid Hybrids Targeting Both Histone Deacetylase and DNA Display High Anticancer Activity via Regulation of the p53 Signaling Pathway.Journal of medicinal chemistry, , Dec-10, Volume: 58, Issue:23, 2015
ST7612AA1, a thioacetate-ω(γ-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors.Journal of medicinal chemistry, , Oct-23, Volume: 57, Issue:20, 2014
Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold.Journal of medicinal chemistry, , Mar-27, Volume: 57, Issue:6, 2014
4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors.European journal of medicinal chemistry, , Apr-09, Volume: 76, 2014
Lactam based 7-amino suberoylamide hydroxamic acids as potent HDAC inhibitors.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 24, Issue:1, 2014
Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoform.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 24, Issue:23, 2014
Methyl effect in azumamides provides insight into histone deacetylase inhibition by macrocycles.Journal of medicinal chemistry, , Nov-26, Volume: 57, Issue:22, 2014
Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.Bioorganic & medicinal chemistry, , Jun-01, Volume: 22, Issue:11, 2014
Search for novel histone deacetylase inhibitors. Part II: design and synthesis of novel isoferulic acid derivatives.Bioorganic & medicinal chemistry, , May-01, Volume: 22, Issue:9, 2014
Quinolone-based HDAC inhibitors.Journal of enzyme inhibition and medicinal chemistry, , Volume: 29, Issue:4, 2014
1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells.Journal of medicinal chemistry, , Jul-24, Volume: 57, Issue:14, 2014
The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 24, Issue:20, 2014
Identification of a novel aminotetralin class of HDAC6 and HDAC8 selective inhibitors.Journal of medicinal chemistry, , Oct-09, Volume: 57, Issue:19, 2014
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity.ACS medicinal chemistry letters, , Sep-11, Volume: 5, Issue:9, 2014
Design, synthesis, and biological evaluation of 1, 3-disubstituted-pyrazole derivatives as new class I and IIb histone deacetylase inhibitors.European journal of medicinal chemistry, , Oct-30, Volume: 86, 2014
Influence of the adamantyl moiety on the activity of biphenylacrylohydroxamic acid-based HDAC inhibitors.European journal of medicinal chemistry, , May-22, Volume: 79, 2014
Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity.Journal of medicinal chemistry, , Apr-24, Volume: 57, Issue:8, 2014
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.Journal of natural products, , Jan-24, Volume: 77, Issue:1, 2014
Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors.Bioorganic & medicinal chemistry, , Jul-15, Volume: 22, Issue:14, 2014
Design, synthesis and biological evaluation of 4-anilinothieno[2,3-d]pyrimidine-based hydroxamic acid derivatives as novel histone deacetylase inhibitors.Bioorganic & medicinal chemistry, , Nov-01, Volume: 22, Issue:21, 2014
Azaindolylsulfonamides, with a more selective inhibitory effect on histone deacetylase 6 activity, exhibit antitumor activity in colorectal cancer HCT116 cells.Journal of medicinal chemistry, , May-22, Volume: 57, Issue:10, 2014
Design and synthesis of a tetrahydroisoquinoline-based hydroxamate derivative (ZYJ-34v), an oral active histone deacetylase inhibitor with potent antitumor activity.Chemical biology & drug design, , Volume: 82, Issue:2, 2013
Synthesis and structure-activity relationship of 3-hydroxypyridine-2-thione-based histone deacetylase inhibitors.Journal of medicinal chemistry, , Dec-27, Volume: 56, Issue:24, 2013
Santacruzamate A, a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp.Journal of natural products, , Nov-22, Volume: 76, Issue:11, 2013
Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease.Journal of medicinal chemistry, , Dec-27, Volume: 56, Issue:24, 2013
Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors.Bioorganic & medicinal chemistry, , Nov-15, Volume: 21, Issue:22, 2013
Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E.Journal of medicinal chemistry, , Aug-22, Volume: 56, Issue:16, 2013
Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2).Bioorganic & medicinal chemistry, , Sep-01, Volume: 21, Issue:17, 2013
Development of a chimeric c-Src kinase and HDAC inhibitor.ACS medicinal chemistry letters, , Aug-08, Volume: 4, Issue:8, 2013
Discovery of the first histone deacetylase 6/8 dual inhibitors.Journal of medicinal chemistry, , Jun-13, Volume: 56, Issue:11, 2013
Design, synthesis and biological evaluation of indeno[1,2-d]thiazole derivatives as potent histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Jun-01, Volume: 23, Issue:11, 2013
Dual-acting histone deacetylase-topoisomerase I inhibitors.Bioorganic & medicinal chemistry letters, , Jun-01, Volume: 23, Issue:11, 2013
The discovery of colchicine-SAHA hybrids as a new class of antitumor agents.Bioorganic & medicinal chemistry, , Jun-01, Volume: 21, Issue:11, 2013
Design and synthesis of dual-action inhibitors targeting histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme A reductase for cancer treatment.Journal of medicinal chemistry, , May-09, Volume: 56, Issue:9, 2013
3-Hydroxypyridin-2-thione as novel zinc binding group for selective histone deacetylase inhibition.Journal of medicinal chemistry, , May-09, Volume: 56, Issue:9, 2013
Development of ACS medicinal chemistry letters, , Feb-14, Volume: 4, Issue:2, 2013
The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase.Bioorganic & medicinal chemistry, , Nov-15, Volume: 21, Issue:22, 2013
Histone deacetylase inhibitors equipped with estrogen receptor modulation activity.Journal of medicinal chemistry, , Jul-25, Volume: 56, Issue:14, 2013
Synthesis and biological characterization of spiro[2H-(1,3)-benzoxazine-2,4'-piperidine] based histone deacetylase inhibitors.European journal of medicinal chemistry, , Volume: 64, 2013
A cyclodextrin-capped histone deacetylase inhibitor.Bioorganic & medicinal chemistry letters, , Jun-01, Volume: 23, Issue:11, 2013
Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability.The Journal of biological chemistry, , Sep-13, Volume: 288, Issue:37, 2013
Design, synthesis and biological evaluation of di-substituted cinnamic hydroxamic acids bearing urea/thiourea unit as potent histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring.European journal of medicinal chemistry, , Volume: 66, 2013
Discovery of a small molecular compound simultaneously targeting RXR and HADC: design, synthesis, molecular docking and bioassay.Bioorganic & medicinal chemistry letters, , Jul-01, Volume: 23, Issue:13, 2013
Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif.Journal of medicinal chemistry, , Feb-28, Volume: 56, Issue:4, 2013
Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells.Journal of medicinal chemistry, , Jan-24, Volume: 56, Issue:2, 2013
CCLab--a multi-objective genetic algorithm based combinatorial library design software and an application for histone deacetylase inhibitor design.Bioorganic & medicinal chemistry letters, , Jul-15, Volume: 22, Issue:14, 2012
Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries.Journal of medicinal chemistry, , Nov-26, Volume: 55, Issue:22, 2012
Set-up of a new series of HDAC inhibitors: the 5,11-dihydrodibenzo[b,e]azepin-6-ones as privileged structures.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 22, Issue:17, 2012
Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.Journal of medicinal chemistry, , Feb-23, Volume: 55, Issue:4, 2012
Synthesis and biological evaluation of 1-arylsulfonyl-5-(N-hydroxyacrylamide)indoles as potent histone deacetylase inhibitors with antitumor activity in vivo.Journal of medicinal chemistry, , Apr-26, Volume: 55, Issue:8, 2012
Discovery and extensive in vitro evaluations of NK-HDAC-1: a chiral histone deacetylase inhibitor as a promising lead.Journal of medicinal chemistry, , Apr-12, Volume: 55, Issue:7, 2012
Synthesis and biochemical analysis of 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoro-N-hydroxy-octanediamides as inhibitors of human histone deacetylases.Bioorganic & medicinal chemistry, , Jan-15, Volume: 20, Issue:2, 2012
The structural requirements of histone deacetylase inhibitors: suberoylanilide hydroxamic acid analogs modified at the C6 position.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 22, Issue:23, 2012
Synthesis and biological evaluation of N-aryl salicylamides with a hydroxamic acid moiety at 5-position as novel HDAC-EGFR dual inhibitors.Bioorganic & medicinal chemistry, , Jul-15, Volume: 20, Issue:14, 2012
Discovery of HDAC Inhibitors That Lack an Active Site Zn(2+)-Binding Functional Group.ACS medicinal chemistry letters, , Jun-14, Volume: 3, Issue:6, 2012
Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors.Journal of medicinal chemistry, , Feb-23, Volume: 55, Issue:4, 2012
Oxime amides as a novel zinc binding group in histone deacetylase inhibitors: synthesis, biological activity, and computational evaluation.Journal of medicinal chemistry, , Apr-14, Volume: 54, Issue:7, 2011
Synthesis and biological evaluation of piperamide analogues as HDAC inhibitors.Bioorganic & medicinal chemistry letters, , Aug-15, Volume: 21, Issue:16, 2011
Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability.Bioorganic & medicinal chemistry, , Jun-15, Volume: 19, Issue:12, 2011
Potential Agents for Treating Cystic Fibrosis: Cyclic Tetrapeptides that Restore Trafficking and Activity of ΔF508-CFTR.ACS medicinal chemistry letters, , Jul-21, Volume: 2, Issue:9, 2011
In vivo PET imaging of histone deacetylases by 18F-suberoylanilide hydroxamic acid (18F-SAHA).Journal of medicinal chemistry, , Aug-11, Volume: 54, Issue:15, 2011
Development of tetrahydroisoquinoline-based hydroxamic acid derivatives: potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities.Journal of medicinal chemistry, , Apr-28, Volume: 54, Issue:8, 2011
Synthesis and evaluation of aliphatic-chain hydroxamates capped with osthole derivatives as histone deacetylase inhibitors.European journal of medicinal chemistry, , Volume: 46, Issue:9, 2011
Structure-based optimization of click-based histone deacetylase inhibitors.European journal of medicinal chemistry, , Volume: 46, Issue:8, 2011
Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 21, Issue:8, 2011
4-N-Hydroxy-4-[1-(sulfonyl)piperidin-4-yl]-butyramides as HDAC inhibitors.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 21, Issue:22, 2011
The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 21, Issue:20, 2011
Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile.Journal of medicinal chemistry, , Jul-14, Volume: 54, Issue:13, 2011
Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity.Journal of medicinal chemistry, , Dec-09, Volume: 53, Issue:23, 2010
Design and synthesis of novel pyrimidine hydroxamic acid inhibitors of histone deacetylases.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 20, Issue:22, 2010
On the inhibition of histone deacetylase 8.Bioorganic & medicinal chemistry, , Jun-01, Volume: 18, Issue:11, 2010
Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeleton.Journal of medicinal chemistry, , Aug-26, Volume: 53, Issue:16, 2010
Discovery of 2-(6-{[(6-fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a class I selective orally active histone deacetylase inhibitor.Journal of medicinal chemistry, , Dec-23, Volume: 53, Issue:24, 2010
Novel chimeric histone deacetylase inhibitors: a series of lapatinib hybrides as potent inhibitors of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and histone deacetylase activity.Journal of medicinal chemistry, , Dec-23, Volume: 53, Issue:24, 2010
New aryldithiolethione derivatives as potent histone deacetylase inhibitors.Bioorganic & medicinal chemistry, , Jun-15, Volume: 18, Issue:12, 2010
Acylurea connected straight chain hydroxamates as novel histone deacetylase inhibitors: Synthesis, SAR, and in vivo antitumor activity.Bioorganic & medicinal chemistry letters, , Jun-01, Volume: 20, Issue:11, 2010
Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents.Journal of medicinal chemistry, , Feb-11, Volume: 53, Issue:3, 2010
Inhibitors selective for HDAC6 in enzymes and cells.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 20, Issue:23, 2010
Chemical phylogenetics of histone deacetylases.Nature chemical biology, , Volume: 6, Issue:3, 2010
SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 20, Issue:6, 2010
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group.Bioorganic & medicinal chemistry, , Jan-01, Volume: 18, Issue:1, 2010
Design and synthesis of novel isoxazole-based HDAC inhibitors.European journal of medicinal chemistry, , Volume: 45, Issue:9, 2010
Biological and biophysical properties of the histone deacetylase inhibitor suberoylanilide hydroxamic acid are affected by the presence of short alkyl groups on the phenyl ring.Journal of medicinal chemistry, , Mar-11, Volume: 53, Issue:5, 2010
Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDc-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer.Journal of medicinal chemistry, , Mar-11, Volume: 53, Issue:5, 2010
Discovery of 1H-benzo[d][1,2,3]triazol-1-yl 3,4,5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase.Bioorganic & medicinal chemistry, , Dec-15, Volume: 18, Issue:24, 2010
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.Nature chemical biology, , Volume: 6, Issue:1, 2010
Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids.Bioorganic & medicinal chemistry, , Jun-01, Volume: 18, Issue:11, 2010
Fluoroalkene modification of mercaptoacetamide-based histone deacetylase inhibitors.Bioorganic & medicinal chemistry, , Jan-15, Volume: 18, Issue:2, 2010
Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model.Bioorganic & medicinal chemistry letters, , Jun-01, Volume: 19, Issue:11, 2009
Isoxazole moiety in the linker region of HDAC inhibitors adjacent to the Zn-chelating group: effects on HDAC biology and antiproliferative activity.Bioorganic & medicinal chemistry letters, , Jun-01, Volume: 19, Issue:11, 2009
Design and synthesis of novel histone deacetylase inhibitor derived from nuclear localization signal peptide.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 19, Issue:23, 2009
Non-isotopic dual parameter competition assay suitable for high-throughput screening of histone deacetylases.Bioorganic & medicinal chemistry letters, , Jul-01, Volume: 19, Issue:13, 2009
Synthesis, biological evaluation, and molecular docking of Ugi products containing a zinc-chelating moiety as novel inhibitors of histone deacetylases.Journal of medicinal chemistry, , May-14, Volume: 52, Issue:9, 2009
Sulfamides as novel histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 19, Issue:2, 2009
Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice.Antimicrobial agents and chemotherapy, , Volume: 53, Issue:5, 2009
Non-peptide macrocyclic histone deacetylase inhibitors.Journal of medicinal chemistry, , Jan-22, Volume: 52, Issue:2, 2009
Discovery of a potent class I selective ketone histone deacetylase inhibitor with antitumor activity in vivo and optimized pharmacokinetic properties.Journal of medicinal chemistry, , Jun-11, Volume: 52, Issue:11, 2009
Design, synthesis, and biological activity of boronic acid-based histone deacetylase inhibitors.Journal of medicinal chemistry, , May-14, Volume: 52, Issue:9, 2009
Novel amide derivatives as inhibitors of histone deacetylase: design, synthesis and SAR.European journal of medicinal chemistry, , Volume: 44, Issue:3, 2009
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.Bioorganic & medicinal chemistry, , Jul-15, Volume: 17, Issue:14, 2009
Design of chimeric histone deacetylase- and tyrosine kinase-inhibitors: a series of imatinib hybrides as potent inhibitors of wild-type and mutant BCR-ABL, PDGF-Rbeta, and histone deacetylases.Journal of medicinal chemistry, , Apr-23, Volume: 52, Issue:8, 2009
Structural origin of selectivity in class II-selective histone deacetylase inhibitors.Journal of medicinal chemistry, , May-22, Volume: 51, Issue:10, 2008
Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.Bioorganic & medicinal chemistry, , May-01, Volume: 16, Issue:9, 2008
Alpha-mercaptoketone based histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 18, Issue:24, 2008
Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6.Journal of medicinal chemistry, , Aug-14, Volume: 51, Issue:15, 2008
Optimization of a series of potent and selective ketone histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 18, Issue:20, 2008
A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo.Journal of medicinal chemistry, , Apr-24, Volume: 51, Issue:8, 2008
Optimization of biaryl Selective HDAC1&2 Inhibitors (SHI-1:2).Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 18, Issue:2, 2008
A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum.Journal of medicinal chemistry, , Jun-26, Volume: 51, Issue:12, 2008
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 18, Issue:6, 2008
Histone deacetylase inhibitors: from bench to clinic.Journal of medicinal chemistry, , Mar-27, Volume: 51, Issue:6, 2008
Trithiocarbonates as a novel class of HDAC inhibitors: SAR studies, isoenzyme selectivity, and pharmacological profiles.Journal of medicinal chemistry, , Jul-10, Volume: 51, Issue:13, 2008
Development of a fluorescence polarization based assay for histone deacetylase ligand discovery.Bioorganic & medicinal chemistry letters, , May-01, Volume: 18, Issue:9, 2008
Structural requirements of HDAC inhibitors: SAHA analogs functionalized adjacent to the hydroxamic acid.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 17, Issue:8, 2007
2-aroylindoles and 2-aroylbenzofurans with N-hydroxyacrylamide substructures as a novel series of rationally designed histone deacetylase inhibitors.Journal of medicinal chemistry, , Sep-06, Volume: 50, Issue:18, 2007
Trithiocarbonates: exploration of a new head group for HDAC inhibitors.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 17, Issue:17, 2007
Structure-activity relationship studies of a series of novel delta-lactam-based histone deacetylase inhibitors.Journal of medicinal chemistry, , May-31, Volume: 50, Issue:11, 2007
Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment.Journal of medicinal chemistry, , Dec-27, Volume: 50, Issue:26, 2007
Pomiferin, histone deacetylase inhibitor isolated from the fruits of Maclura pomifera.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 17, Issue:17, 2007
Modification of cap group in delta-lactam-based histone deacetylase (HDAC) inhibitors.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 17, Issue:22, 2007
The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor.Journal of medicinal chemistry, , Nov-15, Volume: 50, Issue:23, 2007
Synthesis, enzymatic inhibition, and cancer cell growth inhibition of novel delta-lactam-based histone deacetylase (HDAC) inhibitors.Bioorganic & medicinal chemistry letters, , Aug-01, Volume: 16, Issue:15, 2006
Aromatic sulfide inhibitors of histone deacetylase based on arylsulfinyl-2,4-hexadienoic acid hydroxyamides.Journal of medicinal chemistry, , Jan-26, Volume: 49, Issue:2, 2006
Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 15, Issue:5, 2005
Identification of a potent non-hydroxamate histone deacetylase inhibitor by mechanism-based drug design.Bioorganic & medicinal chemistry letters, , Jan-17, Volume: 15, Issue:2, 2005
Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.Journal of medicinal chemistry, , Feb-24, Volume: 48, Issue:4, 2005
Thiol-based SAHA analogues as potent histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Jun-21, Volume: 14, Issue:12, 2004
Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group.Bioorganic & medicinal chemistry letters, , Jan-19, Volume: 14, Issue:2, 2004
Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-based non-hydroxamates.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 13, Issue:24, 2003
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824).Journal of medicinal chemistry, , Oct-09, Volume: 46, Issue:21, 2003
Heterocyclic ketones as inhibitors of histone deacetylase.Bioorganic & medicinal chemistry letters, , Nov-17, Volume: 13, Issue:22, 2003
Histone deacetylase inhibitors.Journal of medicinal chemistry, , Nov-20, Volume: 46, Issue:24, 2003
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC).Bioorganic & medicinal chemistry letters, , Oct-21, Volume: 12, Issue:20, 2002
Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates.Journal of medicinal chemistry, , Feb-14, Volume: 45, Issue:4, 2002
[no title available],
Role of Fluorination in the Histone Deacetylase 6 (HDAC6) Selectivity of Benzohydroxamate-Based Inhibitors.ACS medicinal chemistry letters, , Nov-11, Volume: 12, Issue:11, 2021
Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation.Journal of medicinal chemistry, , 12-12, Volume: 62, Issue:23, 2019
Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif.Journal of medicinal chemistry, , Feb-28, Volume: 56, Issue:4, 2013
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor.Bioorganic & medicinal chemistry letters, , 01-01, Volume: 29, Issue:1, 2019
Histone deacetylase 7 promotes Toll-like receptor 4-dependent proinflammatory gene expression in macrophages.The Journal of biological chemistry, , Aug-30, Volume: 288, Issue:35, 2013
Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease.Journal of medicinal chemistry, , Dec-27, Volume: 56, Issue:24, 2013
Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Oct-01, Volume: 19, Issue:19, 2009
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824).Journal of medicinal chemistry, , Oct-09, Volume: 46, Issue:21, 2003
Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates.Journal of medicinal chemistry, , Feb-14, Volume: 45, Issue:4, 2002
Synthesis and biological evaluation of aminobenzamides containing purine moiety as class I histone deacetylases inhibitors.Bioorganic & medicinal chemistry, , 02-15, Volume: 56, 2022
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.Journal of medicinal chemistry, , 02-24, Volume: 65, Issue:4, 2022
Accommodation of ring C expanded deoxyvasicinone in the HDAC inhibitory pharmacophore culminates into a tractable anti-lung cancer agent and pH-responsive nanocarrier.European journal of medicinal chemistry, , Oct-05, Volume: 240, 2022
Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors.European journal of medicinal chemistry, , Oct-05, Volume: 240, 2022
Effect of phenylurea hydroxamic acids on histone deacetylase and VEGFR-2.Bioorganic & medicinal chemistry, , 11-15, Volume: 50, 2021
Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010-2020).European journal of medicinal chemistry, , Dec-15, Volume: 226, 2021
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model.Journal of medicinal chemistry, , 04-22, Volume: 64, Issue:8, 2021
Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors.Bioorganic & medicinal chemistry, , 04-01, Volume: 35, 2021
Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma.European journal of medicinal chemistry, , May-05, Volume: 217, 2021
Ulleunganilines A-C, Trichostatin Analogues Bearing a Modified Side Chain from Journal of natural products, , 09-24, Volume: 84, Issue:9, 2021
A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles.European journal of medicinal chemistry, , Oct-15, Volume: 222, 2021
Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC Inhibitors.Journal of medicinal chemistry, , 04-23, Volume: 63, Issue:8, 2020
Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6.Journal of medicinal chemistry, , 01-09, Volume: 63, Issue:1, 2020
Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment.European journal of medicinal chemistry, , Feb-01, Volume: 187, 2020
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.Journal of medicinal chemistry, , 01-09, Volume: 63, Issue:1, 2020
Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo.European journal of medicinal chemistry, , Mar-15, Volume: 190, 2020
Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.Bioorganic & medicinal chemistry letters, , 04-15, Volume: 30, Issue:8, 2020
Synthesis and biological evaluation of 2-quinolineacrylamides.Bioorganic & medicinal chemistry, , 02-01, Volume: 28, Issue:3, 2020
Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models.Journal of medicinal chemistry, , 09-26, Volume: 62, Issue:18, 2019
Structure-activity relationship study of thiazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.Bioorganic & medicinal chemistry, , 08-01, Volume: 27, Issue:15, 2019
Identification of novel quinazoline derivatives as potent antiplasmodial agents.European journal of medicinal chemistry, , Jan-01, Volume: 161, 2019
1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase.European journal of medicinal chemistry, , Jan-15, Volume: 162, 2019
Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor.European journal of medicinal chemistry, , Dec-15, Volume: 184, 2019
Highly fluorescent and HDAC6 selective scriptaid analogues.European journal of medicinal chemistry, , Jan-15, Volume: 162, 2019
Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4.Journal of medicinal chemistry, , Aug-09, Volume: 61, Issue:15, 2018
1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC.European journal of medicinal chemistry, , Apr-25, Volume: 150, 2018
Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors.European journal of medicinal chemistry, , Jan-01, Volume: 143, 2018
Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors.Journal of medicinal chemistry, , 04-26, Volume: 61, Issue:8, 2018
Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors.European journal of medicinal chemistry, , May-25, Volume: 152, 2018
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease.European journal of medicinal chemistry, , Apr-25, Volume: 150, 2018
(N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo.Journal of medicinal chemistry, , 02-08, Volume: 61, Issue:3, 2018
Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome Inhibitor.Journal of medicinal chemistry, , 11-21, Volume: 61, Issue:22, 2018
5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer's Disease Phenotypes.Journal of medicinal chemistry, , 08-23, Volume: 61, Issue:16, 2018
HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors.European journal of medicinal chemistry, , Oct-05, Volume: 158, 2018
3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity.European journal of medicinal chemistry, , Jan-05, Volume: 125, 2017
Design and Synthesis of Mercaptoacetamides as Potent, Selective, and Brain Permeable Histone Deacetylase 6 Inhibitors.ACS medicinal chemistry letters, , May-11, Volume: 8, Issue:5, 2017
Design, Synthesis, and Pharmacological Evaluation of Novel N-Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors.Journal of medicinal chemistry, , Jan-28, Volume: 59, Issue:2, 2016
Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors.Bioorganic & medicinal chemistry letters, , 11-01, Volume: 26, Issue:21, 2016
Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.Journal of medicinal chemistry, , Feb-25, Volume: 59, Issue:4, 2016
Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity.European journal of medicinal chemistry, , Jun-30, Volume: 116, 2016
Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 26, Issue:1, 2016
Synthesis of a selective HDAC6 inhibitor active in neuroblasts.Bioorganic & medicinal chemistry letters, , 10-15, Volume: 26, Issue:20, 2016
Can Small Chemical Modifications of Natural Pan-inhibitors Modulate the Biological Selectivity? The Case of Curcumin Prenylated Derivatives Acting as HDAC or mPGES-1 Inhibitors.Journal of natural products, , Dec-24, Volume: 78, Issue:12, 2015
Discovery of 1-hydroxypyridine-2-thiones as selective histone deacetylase inhibitors and their potential application for treating leukemia.Bioorganic & medicinal chemistry letters, , Oct-01, Volume: 25, Issue:19, 2015
New macrocyclic analogs of the natural histone deacetylase inhibitor FK228; design, synthesis and preliminary biological evaluation.Bioorganic & medicinal chemistry, , Nov-01, Volume: 23, Issue:21, 2015
Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT).Bioorganic & medicinal chemistry, , Aug-15, Volume: 23, Issue:16, 2015
Aurones as histone deacetylase inhibitors: identification of key features.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 24, Issue:23, 2014
Influence of the adamantyl moiety on the activity of biphenylacrylohydroxamic acid-based HDAC inhibitors.European journal of medicinal chemistry, , May-22, Volume: 79, 2014
Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease.Journal of medicinal chemistry, , Sep-12, Volume: 56, Issue:17, 2013
Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2).Bioorganic & medicinal chemistry, , Sep-01, Volume: 21, Issue:17, 2013
Tropolones as lead-like natural products: the development of potent and selective histone deacetylase inhibitors.ACS medicinal chemistry letters, , Aug-08, Volume: 4, Issue:8, 2013
The antiparasitic clioquinol induces apoptosis in leukemia and myeloma cells by inhibiting histone deacetylase activity.The Journal of biological chemistry, , Nov-22, Volume: 288, Issue:47, 2013
Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability.The Journal of biological chemistry, , Sep-13, Volume: 288, Issue:37, 2013
Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells.Journal of medicinal chemistry, , Jan-24, Volume: 56, Issue:2, 2013
Cyclic tetrapeptides with thioacetate tails or intramolecular disulfide bridge as potent inhibitors of histone deacetylases.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 22, Issue:21, 2012
Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth.Journal of medicinal chemistry, , Nov-26, Volume: 55, Issue:22, 2012
Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors.Bioorganic & medicinal chemistry, , Aug-01, Volume: 19, Issue:15, 2011
Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.Journal of medicinal chemistry, , Jul-14, Volume: 54, Issue:13, 2011
Structure-based optimization of click-based histone deacetylase inhibitors.European journal of medicinal chemistry, , Volume: 46, Issue:8, 2011
Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 21, Issue:4, 2011
Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity.Journal of medicinal chemistry, , Dec-09, Volume: 53, Issue:23, 2010
On the inhibition of histone deacetylase 8.Bioorganic & medicinal chemistry, , Jun-01, Volume: 18, Issue:11, 2010
Inside HDAC with HDAC inhibitors.European journal of medicinal chemistry, , Volume: 45, Issue:6, 2010
Bicyclic peptides as potent inhibitors of histone deacetylases: optimization of alkyl loop length.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 20, Issue:3, 2010
Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222.Bioorganic & medicinal chemistry, , May-01, Volume: 18, Issue:9, 2010
Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents.Journal of medicinal chemistry, , Feb-11, Volume: 53, Issue:3, 2010
Inhibitors selective for HDAC6 in enzymes and cells.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 20, Issue:23, 2010
Chemical phylogenetics of histone deacetylases.Nature chemical biology, , Volume: 6, Issue:3, 2010
SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 20, Issue:6, 2010
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group.Bioorganic & medicinal chemistry, , Jan-01, Volume: 18, Issue:1, 2010
Discovery of 1H-benzo[d][1,2,3]triazol-1-yl 3,4,5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase.Bioorganic & medicinal chemistry, , Dec-15, Volume: 18, Issue:24, 2010
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.Nature chemical biology, , Volume: 6, Issue:1, 2010
Non-isotopic dual parameter competition assay suitable for high-throughput screening of histone deacetylases.Bioorganic & medicinal chemistry letters, , Jul-01, Volume: 19, Issue:13, 2009
Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 19, Issue:3, 2009
Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides.Journal of medicinal chemistry, , Dec-10, Volume: 52, Issue:23, 2009
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.Bioorganic & medicinal chemistry, , Jul-15, Volume: 17, Issue:14, 2009
N-Hydroxy-(4-oxime)-cinnamide: a versatile scaffold for the synthesis of novel histone deacetylase [correction of deacetilase] (HDAC) inhibitors.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 19, Issue:8, 2009
Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.Bioorganic & medicinal chemistry, , May-01, Volume: 16, Issue:9, 2008
Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6.Journal of medicinal chemistry, , Aug-14, Volume: 51, Issue:15, 2008
Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides.Bioorganic & medicinal chemistry, , Jan-01, Volume: 16, Issue:1, 2008
A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum.Journal of medicinal chemistry, , Jun-26, Volume: 51, Issue:12, 2008
Histone deacetylase inhibitors: from bench to clinic.Journal of medicinal chemistry, , Mar-27, Volume: 51, Issue:6, 2008
Development of a fluorescence polarization based assay for histone deacetylase ligand discovery.Bioorganic & medicinal chemistry letters, , May-01, Volume: 18, Issue:9, 2008
Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells.Bioorganic & medicinal chemistry letters, , May-01, Volume: 18, Issue:9, 2008
Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 17, Issue:17, 2007
Design and synthesis of a potent histone deacetylase inhibitor.Journal of medicinal chemistry, , May-03, Volume: 50, Issue:9, 2007
Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate.Journal of medicinal chemistry, , Aug-10, Volume: 49, Issue:16, 2006
Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 15, Issue:5, 2005
Design and synthesis of phthalimide-type histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 15, Issue:20, 2005
Stereodefined and polyunsaturated inhibitors of histone deacetylase based on (2E,4E)-5-arylpenta-2,4-dienoic acid hydroxyamides.Bioorganic & medicinal chemistry letters, , May-17, Volume: 14, Issue:10, 2004
Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 14, Issue:21, 2004
Subtype selective substrates for histone deacetylases.Journal of medicinal chemistry, , Oct-07, Volume: 47, Issue:21, 2004
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824).Journal of medicinal chemistry, , Oct-09, Volume: 46, Issue:21, 2003
Heterocyclic ketones as inhibitors of histone deacetylase.Bioorganic & medicinal chemistry letters, , Nov-17, Volume: 13, Issue:22, 2003
Histone deacetylase inhibitors.Journal of medicinal chemistry, , Nov-20, Volume: 46, Issue:24, 2003
Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates.Journal of medicinal chemistry, , Feb-14, Volume: 45, Issue:4, 2002
Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives.Journal of medicinal chemistry, , Jul-29, Volume: 42, Issue:15, 1999
Identification of new quinic acid derivatives as histone deacetylase inhibitors by fluorescence-based cellular assay.Bioorganic & medicinal chemistry letters, , May-01, Volume: 26, Issue:9, 2016
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.Bioorganic & medicinal chemistry, , Jul-15, Volume: 17, Issue:14, 2009
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.European journal of medicinal chemistry, , Jan-01, Volume: 209, 2021
Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC.European journal of medicinal chemistry, , Feb-15, Volume: 109, 2016
Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 25, Issue:22, 2015
New aryldithiolethione derivatives as potent histone deacetylase inhibitors.Bioorganic & medicinal chemistry, , Jun-15, Volume: 18, Issue:12, 2010
New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 18, Issue:6, 2008
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.Bioorganic & medicinal chemistry, , Jul-15, Volume: 17, Issue:14, 2009
Histone deacetylase inhibitors.Journal of medicinal chemistry, , Nov-20, Volume: 46, Issue:24, 2003
Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives.Journal of medicinal chemistry, , Jul-29, Volume: 42, Issue:15, 1999
HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors.European journal of medicinal chemistry, , Oct-05, Volume: 158, 2018
Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities.MedChemComm, , Jun-01, Volume: 8, Issue:6, 2017
Novel β-Carboline/Hydroxamic Acid Hybrids Targeting Both Histone Deacetylase and DNA Display High Anticancer Activity via Regulation of the p53 Signaling Pathway.Journal of medicinal chemistry, , Dec-10, Volume: 58, Issue:23, 2015
Novel thiol-based histone deacetylase inhibitors bearing 3-phenyl-1H-pyrazole-5-carboxamide scaffold as surface recognition motif: Design, synthesis and SAR study.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 26, Issue:2, 2016
Discovery of Novel Class I Histone Deacetylase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities.Journal of medicinal chemistry, , Oct-08, Volume: 58, Issue:19, 2015
New macrocyclic analogs of the natural histone deacetylase inhibitor FK228; design, synthesis and preliminary biological evaluation.Bioorganic & medicinal chemistry, , Nov-01, Volume: 23, Issue:21, 2015
Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E.Journal of medicinal chemistry, , Aug-22, Volume: 56, Issue:16, 2013
Total synthesis of bicyclic depsipeptides spiruchostatins C and D and investigation of their histone deacetylase inhibitory and antiproliferative activities.European journal of medicinal chemistry, , Volume: 60, 2013
Discovery and activity profiling of thailandepsins A through F, potent histone deacetylase inhibitors, from MedChemComm, , Aug-01, Volume: 3, Issue:8, 2012
Cyclic tetrapeptides with thioacetate tails or intramolecular disulfide bridge as potent inhibitors of histone deacetylases.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 22, Issue:21, 2012
Discovery of HDAC Inhibitors That Lack an Active Site Zn(2+)-Binding Functional Group.ACS medicinal chemistry letters, , Jun-14, Volume: 3, Issue:6, 2012
Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability.Bioorganic & medicinal chemistry, , Jun-15, Volume: 19, Issue:12, 2011
Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities.Journal of natural products, , Oct-28, Volume: 74, Issue:10, 2011
Chemical phylogenetics of histone deacetylases.Nature chemical biology, , Volume: 6, Issue:3, 2010
Development of a fluorescence polarization based assay for histone deacetylase ligand discovery.Bioorganic & medicinal chemistry letters, , May-01, Volume: 18, Issue:9, 2008
The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor.Journal of medicinal chemistry, , Nov-15, Volume: 50, Issue:23, 2007
Discovery of (aryloxopropenyl)pyrrolyl hydroxyamides as selective inhibitors of class IIa histone deacetylase homologue HD1-A.Journal of medicinal chemistry, , Nov-06, Volume: 46, Issue:23, 2003
Histone deacetylase inhibitors.Journal of medicinal chemistry, , Nov-20, Volume: 46, Issue:24, 2003
[no title available]ACS medicinal chemistry letters, , Jan-14, Volume: 12, Issue:1, 2021
Synthesis, biological evaluation and molecular modeling studies of psammaplin A and its analogs as potent histone deacetylases inhibitors and cytotoxic agents.Bioorganic & medicinal chemistry letters, , 09-01, Volume: 26, Issue:17, 2016
Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.Journal of medicinal chemistry, , Feb-23, Volume: 55, Issue:4, 2012
Histone deacetylase inhibitors.Journal of medicinal chemistry, , Nov-20, Volume: 46, Issue:24, 2003
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms.European journal of medicinal chemistry, , Apr-25, Volume: 150, 2018
Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT).Bioorganic & medicinal chemistry, , Aug-15, Volume: 23, Issue:16, 2015
Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity.Journal of medicinal chemistry, , Dec-09, Volume: 53, Issue:23, 2010
Chemical phylogenetics of histone deacetylases.Nature chemical biology, , Volume: 6, Issue:3, 2010
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 18, Issue:6, 2008
Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity.Journal of medicinal chemistry, , Nov-15, Volume: 50, Issue:23, 2007
Histone deacetylase inhibitors.Journal of medicinal chemistry, , Nov-20, Volume: 46, Issue:24, 2003
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824).Journal of medicinal chemistry, , Oct-09, Volume: 46, Issue:21, 2003
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.Journal of medicinal chemistry, , 02-24, Volume: 65, Issue:4, 2022
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype.Journal of medicinal chemistry, , 03-11, Volume: 64, Issue:5, 2021
Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010-2020).European journal of medicinal chemistry, , Dec-15, Volume: 226, 2021
Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors.European journal of medicinal chemistry, , Oct-05, Volume: 221, 2021
HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates.Journal of medicinal chemistry, , 02-25, Volume: 64, Issue:4, 2021
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.Journal of medicinal chemistry, , 01-09, Volume: 63, Issue:1, 2020
Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.Journal of medicinal chemistry, , 02-14, Volume: 62, Issue:3, 2019
Highly fluorescent and HDAC6 selective scriptaid analogues.European journal of medicinal chemistry, , Jan-15, Volume: 162, 2019
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease.European journal of medicinal chemistry, , Apr-25, Volume: 150, 2018
Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT).Bioorganic & medicinal chemistry, , Aug-15, Volume: 23, Issue:16, 2015
Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoform.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 24, Issue:23, 2014
Development and therapeutic implications of selective histone deacetylase 6 inhibitors.Journal of medicinal chemistry, , Aug-22, Volume: 56, Issue:16, 2013
Potent histone deacetylase inhibitors derived from 4-(aminomethyl)-N-hydroxybenzamide with high selectivity for the HDAC6 isoform.Journal of medicinal chemistry, , Sep-26, Volume: 56, Issue:18, 2013
On the inhibition of histone deacetylase 8.Bioorganic & medicinal chemistry, , Jun-01, Volume: 18, Issue:11, 2010
Chemical phylogenetics of histone deacetylases.Nature chemical biology, , Volume: 6, Issue:3, 2010
Structural origin of selectivity in class II-selective histone deacetylase inhibitors.Journal of medicinal chemistry, , May-22, Volume: 51, Issue:10, 2008
Diversity-oriented synthesis: exploring the intersections between chemistry and biology.Nature chemical biology, , Volume: 1, Issue:2, 2005
Discovery of (aryloxopropenyl)pyrrolyl hydroxyamides as selective inhibitors of class IIa histone deacetylase homologue HD1-A.Journal of medicinal chemistry, , Nov-06, Volume: 46, Issue:23, 2003
Cyclic tetrapeptide HDAC inhibitors as potential therapeutics for spinal muscular atrophy: Screening with iPSC-derived neuronal cells.Bioorganic & medicinal chemistry letters, , 08-01, Volume: 27, Issue:15, 2017
Macrocyclic peptoid-Peptide hybrids as inhibitors of class I histone deacetylases.ACS medicinal chemistry letters, , Sep-13, Volume: 3, Issue:9, 2012
Potential Agents for Treating Cystic Fibrosis: Cyclic Tetrapeptides that Restore Trafficking and Activity of ΔF508-CFTR.ACS medicinal chemistry letters, , Jul-21, Volume: 2, Issue:9, 2011
On the inhibition of histone deacetylase 8.Bioorganic & medicinal chemistry, , Jun-01, Volume: 18, Issue:11, 2010
Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides.Journal of medicinal chemistry, , Dec-10, Volume: 52, Issue:23, 2009
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 18, Issue:6, 2008
Development of a fluorescence polarization based assay for histone deacetylase ligand discovery.Bioorganic & medicinal chemistry letters, , May-01, Volume: 18, Issue:9, 2008
Histone deacetylase inhibitors.Journal of medicinal chemistry, , Nov-20, Volume: 46, Issue:24, 2003
Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure-activity relationships of apicidin. Part 2.Bioorganic & medicinal chemistry letters, , Jan-22, Volume: 11, Issue:2, 2001
Synthesis of apicidin-derived quinolone derivatives: parasite-selective histone deacetylase inhibitors and antiproliferative agents.Journal of medicinal chemistry, , Dec-14, Volume: 43, Issue:25, 2000
HIV latency reversal agents: A potential path for functional cure?European journal of medicinal chemistry, , Mar-05, Volume: 213, 2021
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.Journal of medicinal chemistry, , 01-09, Volume: 63, Issue:1, 2020
Design, synthesis and activity evaluation of indole-based double - Branched HDAC1 inhibitors.Bioorganic & medicinal chemistry, , 04-15, Volume: 27, Issue:8, 2019
Indole: A privileged scaffold for the design of anti-cancer agents.European journal of medicinal chemistry, , Dec-01, Volume: 183, 2019
Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors.European journal of medicinal chemistry, , Apr-25, Volume: 150, 2018
Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors.ACS medicinal chemistry letters, , Feb-08, Volume: 9, Issue:2, 2018
4-Indolyl-N-hydroxyphenylacrylamides as potent HDAC class I and IIB inhibitors in vitro and in vivo.European journal of medicinal chemistry, , Jul-07, Volume: 134, 2017
Design, synthesis, and preliminary bioactivity evaluation of NChemical biology & drug design, , Volume: 89, Issue:1, 2017
PXD101 analogs with L-phenylglycine-containing branched cap as histone deacetylase inhibitors.Chemical biology & drug design, , Volume: 88, Issue:4, 2016
2-(Phenylsulfonyl)quinoline N-hydroxyacrylamides as potent anticancer agents inhibiting histone deacetylase.European journal of medicinal chemistry, , Oct-21, Volume: 122, 2016
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition.Nature chemical biology, , Volume: 12, Issue:9, 2016
Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT).Bioorganic & medicinal chemistry, , Aug-15, Volume: 23, Issue:16, 2015
Indole-3-ethylsulfamoylphenylacrylamides: potent histone deacetylase inhibitors with anti-inflammatory activity.European journal of medicinal chemistry, , Oct-06, Volume: 85, 2014
Design, synthesis and biological evaluation of indeno[1,2-d]thiazole derivatives as potent histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Jun-01, Volume: 23, Issue:11, 2013
Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile.Journal of medicinal chemistry, , Jul-14, Volume: 54, Issue:13, 2011
Chemical phylogenetics of histone deacetylases.Nature chemical biology, , Volume: 6, Issue:3, 2010
Histone deacetylase inhibitors: from bench to clinic.Journal of medicinal chemistry, , Mar-27, Volume: 51, Issue:6, 2008
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 18, Issue:6, 2008
A review on the treatment of multiple myeloma with small molecular agents in the past five years.European journal of medicinal chemistry, , Feb-05, Volume: 229, 2022
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.Journal of medicinal chemistry, , 02-24, Volume: 65, Issue:4, 2022
[no title available]Journal of medicinal chemistry, , 10-28, Volume: 64, Issue:20, 2021
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with Journal of medicinal chemistry, , 03-25, Volume: 64, Issue:6, 2021
Synthesis and in Vitro and in Vivo Biological Evaluation of Tissue-Specific Bisthiazole Histone Deacetylase (HDAC) Inhibitors.Journal of medicinal chemistry, , 01-23, Volume: 63, Issue:2, 2020
Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity.Journal of medicinal chemistry, , 05-28, Volume: 63, Issue:10, 2020
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.Journal of medicinal chemistry, , 01-09, Volume: 63, Issue:1, 2020
Novel α,β-unsaturated hydroxamic acid derivatives overcome cisplatin resistance.Bioorganic & medicinal chemistry, , 10-01, Volume: 27, Issue:19, 2019
Indole: A privileged scaffold for the design of anti-cancer agents.European journal of medicinal chemistry, , Dec-01, Volume: 183, 2019
Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy.Journal of medicinal chemistry, , 04-11, Volume: 62, Issue:7, 2019
Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma.Bioorganic & medicinal chemistry letters, , 09-15, Volume: 28, Issue:17, 2018
Design and synthesis of benzodiazepine analogs as isoform-selective human lysine deacetylase inhibitors.European journal of medicinal chemistry, , Feb-15, Volume: 127, 2017
An Isochemogenic Set of Inhibitors To Define the Therapeutic Potential of Histone Deacetylases in β-Cell Protection.ACS chemical biology, , Feb-19, Volume: 11, Issue:2, 2016
Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazoline as the Cap for the Treatment of Cancer.Journal of medicinal chemistry, , Feb-25, Volume: 59, Issue:4, 2016
Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease.Journal of medicinal chemistry, , 10-13, Volume: 59, Issue:19, 2016
Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors.Bioorganic & medicinal chemistry, , 09-15, Volume: 24, Issue:18, 2016
Development of Purine-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities.Journal of medicinal chemistry, , 06-09, Volume: 59, Issue:11, 2016
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition.Nature chemical biology, , Volume: 12, Issue:9, 2016
Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT).Bioorganic & medicinal chemistry, , Aug-15, Volume: 23, Issue:16, 2015
Discovery of the first histone deacetylase 6/8 dual inhibitors.Journal of medicinal chemistry, , Jun-13, Volume: 56, Issue:11, 2013
Design, synthesis and biological evaluation of indeno[1,2-d]thiazole derivatives as potent histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Jun-01, Volume: 23, Issue:11, 2013
Biocatalytic synthesis and structure elucidation of cyclized metabolites of the deacetylase inhibitor panobinostat (LBH589).Drug metabolism and disposition: the biological fate of chemicals, , Volume: 40, Issue:5, 2012
Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile.Journal of medicinal chemistry, , Jul-14, Volume: 54, Issue:13, 2011
Chemical phylogenetics of histone deacetylases.Nature chemical biology, , Volume: 6, Issue:3, 2010
HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates.Journal of medicinal chemistry, , 02-25, Volume: 64, Issue:4, 2021
Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors.Journal of medicinal chemistry, , Aug-25, Volume: 48, Issue:17, 2005
LSD1 Substrate Binding and Gene Expression Are Affected by HDAC1-Mediated Deacetylation.ACS chemical biology, , 01-20, Volume: 12, Issue:1, 2017
An Isochemogenic Set of Inhibitors To Define the Therapeutic Potential of Histone Deacetylases in β-Cell Protection.ACS chemical biology, , Feb-19, Volume: 11, Issue:2, 2016
Mutagenesis studies of the 14 Å internal cavity of histone deacetylase 1: insights toward the acetate-escape hypothesis and selective inhibitor design.Journal of medicinal chemistry, , Feb-13, Volume: 57, Issue:3, 2014
Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability.The Journal of biological chemistry, , Sep-13, Volume: 288, Issue:37, 2013
Inside HDAC with HDAC inhibitors.European journal of medicinal chemistry, , Volume: 45, Issue:6, 2010
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2).Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 18, Issue:3, 2008
Histone deacetylase inhibitors: from bench to clinic.Journal of medicinal chemistry, , Mar-27, Volume: 51, Issue:6, 2008
Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity.Journal of medicinal chemistry, , Nov-15, Volume: 50, Issue:23, 2007
Comparison of three zinc binding groups for HDAC inhibitors - A potency, selectivity and enzymatic kinetics study.Bioorganic & medicinal chemistry letters, , 08-15, Volume: 70, 2022
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia.Nature chemical biology, , Volume: 2, Issue:10, 2006
Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.Journal of medicinal chemistry, , Feb-24, Volume: 48, Issue:4, 2005
Thiol-based SAHA analogues as potent histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Jun-21, Volume: 14, Issue:12, 2004
Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-based non-hydroxamates.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 13, Issue:24, 2003
Discovery of novel cyclin-dependent kinase (CDK) and histone deacetylase (HDAC) dual inhibitors with potent in vitro and in vivo anticancer activity.European journal of medicinal chemistry, , Mar-01, Volume: 189, 2020
Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.European journal of medicinal chemistry, , Jul-01, Volume: 173, 2019
Thioether-based 2-aminobenzamide derivatives: Novel HDAC inhibitors with potent in vitro and in vivo antitumor activity.European journal of medicinal chemistry, , Aug-15, Volume: 176, 2019
Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents.European journal of medicinal chemistry, , Jan-01, Volume: 143, 2018
Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia.Journal of medicinal chemistry, , 11-24, Volume: 65, Issue:22, 2022
Role of Fluorination in the Histone Deacetylase 6 (HDAC6) Selectivity of Benzohydroxamate-Based Inhibitors.ACS medicinal chemistry letters, , Nov-11, Volume: 12, Issue:11, 2021
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation.Journal of medicinal chemistry, , 12-12, Volume: 62, Issue:23, 2019
Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT).Bioorganic & medicinal chemistry, , Aug-15, Volume: 23, Issue:16, 2015
Chemical phylogenetics of histone deacetylases.Nature chemical biology, , Volume: 6, Issue:3, 2010
[no title available]Journal of medicinal chemistry, , 11-25, Volume: 64, Issue:22, 2021
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.Journal of medicinal chemistry, , Aug-08, Volume: 56, Issue:15, 2013
Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth.Journal of medicinal chemistry, , Nov-26, Volume: 55, Issue:22, 2012
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 19, Issue:3, 2009
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 18, Issue:6, 2008
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.Journal of medicinal chemistry, , Jul-24, Volume: 51, Issue:14, 2008
Histone deacetylase inhibitors: from bench to clinic.Journal of medicinal chemistry, , Mar-27, Volume: 51, Issue:6, 2008
[no title available]Journal of medicinal chemistry, , 03-10, Volume: 65, Issue:5, 2022
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with Journal of medicinal chemistry, , 03-25, Volume: 64, Issue:6, 2021
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma.Bioorganic & medicinal chemistry letters, , 09-15, Volume: 28, Issue:17, 2018
Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease.Journal of medicinal chemistry, , 10-13, Volume: 59, Issue:19, 2016
Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT).Bioorganic & medicinal chemistry, , Aug-15, Volume: 23, Issue:16, 2015
Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6.Journal of medicinal chemistry, , 01-09, Volume: 63, Issue:1, 2020
Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.Bioorganic & medicinal chemistry letters, , 04-15, Volume: 30, Issue:8, 2020
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT).Bioorganic & medicinal chemistry, , Aug-15, Volume: 23, Issue:16, 2015
CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo.Molecular cancer therapeutics, , Volume: 5, Issue:5, 2006
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.European journal of medicinal chemistry, , Jan-01, Volume: 209, 2021
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
[no title available],
Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E.Journal of medicinal chemistry, , Aug-22, Volume: 56, Issue:16, 2013
Histone deacetylase inhibitors: from bench to clinic.Journal of medicinal chemistry, , Mar-27, Volume: 51, Issue:6, 2008
Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells.Bioorganic & medicinal chemistry letters, , May-01, Volume: 18, Issue:9, 2008
Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors.European journal of medicinal chemistry, , Oct-05, Volume: 240, 2022
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting.Journal of medicinal chemistry, , 08-13, Volume: 63, Issue:15, 2020
Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4.Journal of medicinal chemistry, , Aug-09, Volume: 61, Issue:15, 2018
Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.Journal of medicinal chemistry, , 11-21, Volume: 61, Issue:22, 2018
Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD).Journal of medicinal chemistry, , 03-08, Volume: 61, Issue:5, 2018
Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity.Journal of medicinal chemistry, , 12-28, Volume: 60, Issue:24, 2017
Development of a Potent and Selective HDAC8 Inhibitor.ACS medicinal chemistry letters, , Oct-13, Volume: 7, Issue:10, 2016
Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.Journal of medicinal chemistry, , Feb-25, Volume: 59, Issue:4, 2016
The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 24, Issue:20, 2014
Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries.Journal of medicinal chemistry, , Nov-26, Volume: 55, Issue:22, 2012
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.European journal of medicinal chemistry, , Jan-01, Volume: 209, 2021
Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy.Journal of medicinal chemistry, , 04-11, Volume: 62, Issue:7, 2019
Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDc-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer.Journal of medicinal chemistry, , Mar-11, Volume: 53, Issue:5, 2010
[no title available],
A fluorine scan on the ZnEuropean journal of medicinal chemistry, , Nov-15, Volume: 182, 2019
Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.Journal of medicinal chemistry, , Feb-25, Volume: 59, Issue:4, 2016
Largazole Analogues Embodying Radical Changes in the Depsipeptide Ring: Development of a More Selective and Highly Potent Analogue.Journal of medicinal chemistry, , 12-08, Volume: 59, Issue:23, 2016
Modular synthesis and biological activity of pyridyl-based analogs of the potent Class I Histone Deacetylase Inhibitor Largazole.Bioorganic & medicinal chemistry, , Aug-01, Volume: 23, Issue:15, 2015
Discovery of Novel Class I Histone Deacetylase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities.Journal of medicinal chemistry, , Oct-08, Volume: 58, Issue:19, 2015
Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors.ACS medicinal chemistry letters, , Jun-12, Volume: 5, Issue:6, 2014
Synthesis and HDAC inhibitory activity of isosteric thiazoline-oxazole largazole analogs.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 23, Issue:21, 2013
Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability.Bioorganic & medicinal chemistry, , Jun-15, Volume: 19, Issue:12, 2011
[no title available]Journal of medicinal chemistry, , 02-10, Volume: 65, Issue:3, 2022
Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models.Journal of medicinal chemistry, , 09-26, Volume: 62, Issue:18, 2019
Development and therapeutic implications of selective histone deacetylase 6 inhibitors.Journal of medicinal chemistry, , Aug-22, Volume: 56, Issue:16, 2013
Inhibitors selective for HDAC6 in enzymes and cells.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 20, Issue:23, 2010
Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6.Journal of medicinal chemistry, , Aug-14, Volume: 51, Issue:15, 2008
Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer's disease.Bioorganic & medicinal chemistry letters, , 11-15, Volume: 76, 2022
Identification of PI3K/HDAC Dual-targeted inhibitors with subtype selectivity as potential therapeutic agents against solid Tumors: Building HDAC6 potency in a Quinazolinone-based PI3Kδ-selective template.Bioorganic & medicinal chemistry, , 11-01, Volume: 73, 2022
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.Journal of medicinal chemistry, , 02-24, Volume: 65, Issue:4, 2022
First-in-Class Dual Mechanism Ferroptosis-HDAC Inhibitor Hybrids.Journal of medicinal chemistry, , 11-10, Volume: 65, Issue:21, 2022
Histone deacetylase 6 inhibitors with blood-brain barrier penetration as a potential strategy for CNS-Disorders therapy.European journal of medicinal chemistry, , Feb-05, Volume: 229, 2022
[no title available]Journal of medicinal chemistry, , 09-22, Volume: 65, Issue:18, 2022
Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia.Journal of medicinal chemistry, , 11-24, Volume: 65, Issue:22, 2022
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype.Journal of medicinal chemistry, , 03-11, Volume: 64, Issue:5, 2021
Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010-2020).European journal of medicinal chemistry, , Dec-15, Volume: 226, 2021
Identification of novel 1,3-diaryl-1,2,4-triazole-capped histone deacetylase 6 inhibitors with potential anti-gastric cancer activity.European journal of medicinal chemistry, , Jun-05, Volume: 218, 2021
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model.Journal of medicinal chemistry, , 04-22, Volume: 64, Issue:8, 2021
Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors.European journal of medicinal chemistry, , Feb-05, Volume: 211, 2021
Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction.European journal of medicinal chemistry, , Jun-05, Volume: 218, 2021
Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis.Journal of medicinal chemistry, , 01-28, Volume: 64, Issue:2, 2021
Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors.European journal of medicinal chemistry, , Oct-05, Volume: 221, 2021
[no title available]Journal of medicinal chemistry, , 10-28, Volume: 64, Issue:20, 2021
Design, synthesis and biological evaluation of dual mTOR/HDAC6 inhibitors in MDA-MB-231 cells.Bioorganic & medicinal chemistry letters, , 09-01, Volume: 47, 2021
A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity.Journal of medicinal chemistry, , 02-11, Volume: 64, Issue:3, 2021
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer's Disease Multitarget Drug Discovery?Journal of medicinal chemistry, , 01-14, Volume: 64, Issue:1, 2021
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation.ACS medicinal chemistry letters, , Nov-12, Volume: 11, Issue:11, 2020
Rational Design of Suprastat: A Novel Selective Histone Deacetylase 6 Inhibitor with the Ability to Potentiate Immunotherapy in Melanoma Models.Journal of medicinal chemistry, , 09-24, Volume: 63, Issue:18, 2020
Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups.Journal of medicinal chemistry, , 09-24, Volume: 63, Issue:18, 2020
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.Journal of medicinal chemistry, , 01-09, Volume: 63, Issue:1, 2020
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
Synthesis and biological evaluation of 2-quinolineacrylamides.Bioorganic & medicinal chemistry, , 02-01, Volume: 28, Issue:3, 2020
Structure-activity relationship study of thiazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.Bioorganic & medicinal chemistry, , 08-01, Volume: 27, Issue:15, 2019
Design, synthesis and biological evaluation of β-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activity.MedChemComm, , Jul-01, Volume: 10, Issue:7, 2019
Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation.Journal of medicinal chemistry, , 12-12, Volume: 62, Issue:23, 2019
Novel α,β-unsaturated hydroxamic acid derivatives overcome cisplatin resistance.Bioorganic & medicinal chemistry, , 10-01, Volume: 27, Issue:19, 2019
Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.Journal of medicinal chemistry, , 02-14, Volume: 62, Issue:3, 2019
Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer.Journal of medicinal chemistry, , 01-24, Volume: 62, Issue:2, 2019
Highly fluorescent and HDAC6 selective scriptaid analogues.European journal of medicinal chemistry, , Jan-15, Volume: 162, 2019
Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated.Journal of medicinal chemistry, , 05-09, Volume: 62, Issue:9, 2019
Merging of ruxolitinib and vorinostat leads to highly potent inhibitors of JAK2 and histone deacetylase 6 (HDAC6).Bioorganic & medicinal chemistry letters, , 08-15, Volume: 28, Issue:15, 2018
Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer's disease.Bioorganic & medicinal chemistry, , 11-15, Volume: 26, Issue:21, 2018
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies.European journal of medicinal chemistry, , Sep-05, Volume: 157, 2018
Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors.Journal of medicinal chemistry, , 04-26, Volume: 61, Issue:8, 2018
Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors.European journal of medicinal chemistry, , May-25, Volume: 152, 2018
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease.European journal of medicinal chemistry, , Apr-25, Volume: 150, 2018
The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.European journal of medicinal chemistry, , Jan-01, Volume: 143, 2018
Recent advances in the discovery of potent and selective HDAC6 inhibitors.European journal of medicinal chemistry, , Jan-01, Volume: 143, 2018
HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors.European journal of medicinal chemistry, , Oct-05, Volume: 158, 2018
LSD1 Substrate Binding and Gene Expression Are Affected by HDAC1-Mediated Deacetylation.ACS chemical biology, , 01-20, Volume: 12, Issue:1, 2017
Structural Requirements of HDAC Inhibitors: SAHA Analogues Modified at the C2 Position Display HDAC6/8 Selectivity.ACS medicinal chemistry letters, , Mar-09, Volume: 8, Issue:3, 2017
Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms.European journal of medicinal chemistry, , Feb-15, Volume: 127, 2017
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat.Journal of medicinal chemistry, , 10-26, Volume: 60, Issue:20, 2017
Discovery of a fluorescent probe with HDAC6 selective inhibition.European journal of medicinal chemistry, , Dec-01, Volume: 141, 2017
Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity.European journal of medicinal chemistry, , Jun-30, Volume: 116, 2016
Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.Journal of medicinal chemistry, , Feb-25, Volume: 59, Issue:4, 2016
Design and Synthesis of Janus Kinase 2 (JAK2) and Histone Deacetlyase (HDAC) Bispecific Inhibitors Based on Pacritinib and Evidence of Dual Pathway Inhibition in Hematological Cell Lines.Journal of medicinal chemistry, , Sep-22, Volume: 59, Issue:18, 2016
Synthesis of a selective HDAC6 inhibitor active in neuroblasts.Bioorganic & medicinal chemistry letters, , 10-15, Volume: 26, Issue:20, 2016
Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators.Journal of medicinal chemistry, , Oct-08, Volume: 58, Issue:19, 2015
Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT).Bioorganic & medicinal chemistry, , Aug-15, Volume: 23, Issue:16, 2015
The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 24, Issue:20, 2014
Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoform.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 24, Issue:23, 2014
Potent histone deacetylase inhibitors derived from 4-(aminomethyl)-N-hydroxybenzamide with high selectivity for the HDAC6 isoform.Journal of medicinal chemistry, , Sep-26, Volume: 56, Issue:18, 2013
Development and therapeutic implications of selective histone deacetylase 6 inhibitors.Journal of medicinal chemistry, , Aug-22, Volume: 56, Issue:16, 2013
Discovery of the first histone deacetylase 6/8 dual inhibitors.Journal of medicinal chemistry, , Jun-13, Volume: 56, Issue:11, 2013
Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease.Journal of medicinal chemistry, , Sep-12, Volume: 56, Issue:17, 2013
Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif.Journal of medicinal chemistry, , Feb-28, Volume: 56, Issue:4, 2013
Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth.Journal of medicinal chemistry, , Nov-26, Volume: 55, Issue:22, 2012
Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells.Journal of medicinal chemistry, , Jan-26, Volume: 55, Issue:2, 2012
Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma.Journal of medicinal chemistry, , 02-22, Volume: 61, Issue:4, 2018
Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT).Bioorganic & medicinal chemistry, , Aug-15, Volume: 23, Issue:16, 2015
Design, synthesis and biological evaluation of di-substituted cinnamic hydroxamic acids bearing urea/thiourea unit as potent histone deacetylase inhibitors.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
Discovery of HDAC6-Selective Inhibitor NN-390 with Journal of medicinal chemistry, , 02-24, Volume: 65, Issue:4, 2022
A review on the treatment of multiple myeloma with small molecular agents in the past five years.European journal of medicinal chemistry, , Feb-05, Volume: 229, 2022
Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer's disease.Bioorganic & medicinal chemistry letters, , 11-15, Volume: 76, 2022
Identification of PI3K/HDAC Dual-targeted inhibitors with subtype selectivity as potential therapeutic agents against solid Tumors: Building HDAC6 potency in a Quinazolinone-based PI3Kδ-selective template.Bioorganic & medicinal chemistry, , 11-01, Volume: 73, 2022
Novel biphenyl-based scaffold as potent and selective histone deacetylase 6 (HDAC6) inhibitors: Identification, development and pharmacological evaluation.European journal of medicinal chemistry, , Apr-05, Volume: 233, 2022
Histone deacetylase 6 inhibitors with blood-brain barrier penetration as a potential strategy for CNS-Disorders therapy.European journal of medicinal chemistry, , Feb-05, Volume: 229, 2022
[no title available]Journal of medicinal chemistry, , 09-22, Volume: 65, Issue:18, 2022
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype.Journal of medicinal chemistry, , 03-11, Volume: 64, Issue:5, 2021
Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010-2020).European journal of medicinal chemistry, , Dec-15, Volume: 226, 2021
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia.Journal of medicinal chemistry, , 06-24, Volume: 64, Issue:12, 2021
A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity.Journal of medicinal chemistry, , 02-11, Volume: 64, Issue:3, 2021
Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors.European journal of medicinal chemistry, , Oct-05, Volume: 221, 2021
Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma.Bioorganic & medicinal chemistry letters, , 02-15, Volume: 34, 2021
Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction.European journal of medicinal chemistry, , Jun-05, Volume: 218, 2021
Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects Journal of medicinal chemistry, , 04-08, Volume: 64, Issue:7, 2021
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups.Journal of medicinal chemistry, , 09-24, Volume: 63, Issue:18, 2020
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.Journal of medicinal chemistry, , 01-09, Volume: 63, Issue:1, 2020
PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia.European journal of medicinal chemistry, , Sep-01, Volume: 201, 2020
Design, synthesis, and bioactivity evaluation of novel Bcl-2/HDAC dual-target inhibitors for the treatment of multiple myeloma.Bioorganic & medicinal chemistry letters, , 02-01, Volume: 29, Issue:3, 2019
Design, synthesis and biological evaluation of β-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activity.MedChemComm, , Jul-01, Volume: 10, Issue:7, 2019
Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models.Journal of medicinal chemistry, , 09-26, Volume: 62, Issue:18, 2019
Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation.Journal of medicinal chemistry, , 12-12, Volume: 62, Issue:23, 2019
Highly fluorescent and HDAC6 selective scriptaid analogues.European journal of medicinal chemistry, , Jan-15, Volume: 162, 2019
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease.European journal of medicinal chemistry, , Apr-25, Volume: 150, 2018
(N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo.Journal of medicinal chemistry, , 02-08, Volume: 61, Issue:3, 2018
Recent advances in the discovery of potent and selective HDAC6 inhibitors.European journal of medicinal chemistry, , Jan-01, Volume: 143, 2018
Design, synthesis and biological evaluation of novel hydroxamic acid based histone deacetylase 6 selective inhibitors bearing phenylpyrazol scaffold as surface recognition motif.Bioorganic & medicinal chemistry, , 05-01, Volume: 26, Issue:8, 2018
Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms.European journal of medicinal chemistry, , Feb-15, Volume: 127, 2017
Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazoline as the Cap for the Treatment of Cancer.Journal of medicinal chemistry, , Feb-25, Volume: 59, Issue:4, 2016
Azaindolylsulfonamides, with a more selective inhibitory effect on histone deacetylase 6 activity, exhibit antitumor activity in colorectal cancer HCT116 cells.Journal of medicinal chemistry, , May-22, Volume: 57, Issue:10, 2014
Development and therapeutic implications of selective histone deacetylase 6 inhibitors.Journal of medicinal chemistry, , Aug-22, Volume: 56, Issue:16, 2013
Histone deacetylase 2: A potential therapeutic target for cancer and neurodegenerative disorders.European journal of medicinal chemistry, , Apr-15, Volume: 216, 2021
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
Design, Synthesis, and Biological Evaluation of 4-Methyl Quinazoline Derivatives as Anticancer Agents Simultaneously Targeting Phosphoinositide 3-Kinases and Histone Deacetylases.Journal of medicinal chemistry, , 08-08, Volume: 62, Issue:15, 2019
Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy.Journal of medicinal chemistry, , 04-11, Volume: 62, Issue:7, 2019
Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma.Journal of medicinal chemistry, , 02-22, Volume: 61, Issue:4, 2018
Designing multi-targeted agents: An emerging anticancer drug discovery paradigm.European journal of medicinal chemistry, , Aug-18, Volume: 136, 2017
Development of Purine-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities.Journal of medicinal chemistry, , 06-09, Volume: 59, Issue:11, 2016
Histone deacetylase 6 inhibitors with blood-brain barrier penetration as a potential strategy for CNS-Disorders therapy.European journal of medicinal chemistry, , Feb-05, Volume: 229, 2022
[no title available]Journal of medicinal chemistry, , 09-22, Volume: 65, Issue:18, 2022
Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010-2020).European journal of medicinal chemistry, , Dec-15, Volume: 226, 2021
Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction.European journal of medicinal chemistry, , Jun-05, Volume: 218, 2021
Design, synthesis and biological evaluation of dual mTOR/HDAC6 inhibitors in MDA-MB-231 cells.Bioorganic & medicinal chemistry letters, , 09-01, Volume: 47, 2021
Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.European journal of medicinal chemistry, , Jan-01, Volume: 209, 2021
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.Journal of medicinal chemistry, , 01-09, Volume: 63, Issue:1, 2020
Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation.Journal of medicinal chemistry, , 12-12, Volume: 62, Issue:23, 2019
Histone deacetylase 6 inhibitors with blood-brain barrier penetration as a potential strategy for CNS-Disorders therapy.European journal of medicinal chemistry, , Feb-05, Volume: 229, 2022
Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010-2020).European journal of medicinal chemistry, , Dec-15, Volume: 226, 2021
Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction.European journal of medicinal chemistry, , Jun-05, Volume: 218, 2021
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.Journal of medicinal chemistry, , 01-09, Volume: 63, Issue:1, 2020
Discovery of HDAC6-Selective Inhibitor NN-390 with Journal of medicinal chemistry, , 02-24, Volume: 65, Issue:4, 2022
[no title available]Journal of medicinal chemistry, , 09-22, Volume: 65, Issue:18, 2022
Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors.European journal of medicinal chemistry, , Oct-05, Volume: 221, 2021
Intracellular fluorescence competition assay for inhibitor engagement of histone deacetylase.Bioorganic & medicinal chemistry letters, , 09-01, Volume: 47, 2021
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model.Journal of medicinal chemistry, , 04-22, Volume: 64, Issue:8, 2021
[no title available]European journal of medicinal chemistry, , Feb-05, Volume: 211, 2021
Rational Design of Suprastat: A Novel Selective Histone Deacetylase 6 Inhibitor with the Ability to Potentiate Immunotherapy in Melanoma Models.Journal of medicinal chemistry, , 09-24, Volume: 63, Issue:18, 2020
Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups.Journal of medicinal chemistry, , 09-24, Volume: 63, Issue:18, 2020
Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity.Journal of medicinal chemistry, , 08-08, Volume: 62, Issue:15, 2019
Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models.Journal of medicinal chemistry, , 09-26, Volume: 62, Issue:18, 2019
Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation.Journal of medicinal chemistry, , 12-12, Volume: 62, Issue:23, 2019
Novel α,β-unsaturated hydroxamic acid derivatives overcome cisplatin resistance.Bioorganic & medicinal chemistry, , 10-01, Volume: 27, Issue:19, 2019
Design, synthesis and evaluate of novel dual FGFR1 and HDAC inhibitors bearing an indazole scaffold.Bioorganic & medicinal chemistry, , 02-01, Volume: 26, Issue:3, 2018
Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth.Journal of medicinal chemistry, , Nov-26, Volume: 55, Issue:22, 2012
Synthesis and biological evaluation of santacruzamate A analogues for anti-proliferative and immunomodulatory activity.Bioorganic & medicinal chemistry, , 11-01, Volume: 24, Issue:21, 2016
Santacruzamate A, a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp.Journal of natural products, , Nov-22, Volume: 76, Issue:11, 2013
Enables
This protein enables 22 target(s):
Target | Category | Definition |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | molecular function | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. [GOC:txnOH-2018] |
transcription corepressor binding | molecular function | Binding to a transcription corepressor, a protein involved in negative regulation of transcription via protein-protein interactions with transcription factors and other proteins that negatively regulate transcription. Transcription corepressors do not bind DNA directly, but rather mediate protein-protein interactions between repressing transcription factors and the basal transcription machinery. [GOC:krc] |
actin binding | molecular function | Binding to monomeric or multimeric forms of actin, including actin filaments. [GOC:clt] |
histone deacetylase activity | molecular function | Catalysis of the reaction: histone N6-acetyl-L-lysine + H2O = histone L-lysine + acetate. This reaction represents the removal of an acetyl group from a histone, a class of proteins complexed to DNA in chromatin and chromosomes. [PMID:9893272, RHEA:58196] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
beta-catenin binding | molecular function | Binding to a catenin beta subunit. [GOC:bf] |
microtubule binding | molecular function | Binding to a microtubule, a filament composed of tubulin monomers. [GOC:krc] |
zinc ion binding | molecular function | Binding to a zinc ion (Zn). [GOC:ai] |
enzyme binding | molecular function | Binding to an enzyme, a protein with catalytic activity. [GOC:jl] |
polyubiquitin modification-dependent protein binding | molecular function | Binding to a protein upon poly-ubiquitination of the target protein. [GOC:pg] |
ubiquitin protein ligase binding | molecular function | Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins. [GOC:vp] |
protein lysine deacetylase activity | molecular function | Catalysis of the reaction: H2O + N6-acetyl-L-lysyl-[protein] = acetate + L-lysyl-[protein]. [PMID:27296530, RHEA:58108] |
histone deacetylase binding | molecular function | Binding to histone deacetylase. [GOC:jl] |
tubulin deacetylase activity | molecular function | Catalysis of the reaction: N-acetyl(alpha-tubulin) + H2O = alpha-tubulin + acetate. [PMID:12024216, PMID:12486003] |
alpha-tubulin binding | molecular function | Binding to the microtubule constituent protein alpha-tubulin. [GOC:jl] |
ubiquitin binding | molecular function | Binding to ubiquitin, a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation. [GOC:ecd] |
tau protein binding | molecular function | Binding to tau protein. tau is a microtubule-associated protein, implicated in Alzheimer's disease, Down Syndrome and ALS. [GOC:jid] |
beta-tubulin binding | molecular function | Binding to the microtubule constituent protein beta-tubulin. [GOC:krc] |
misfolded protein binding | molecular function | Binding to a misfolded protein. [GOC:ai] |
Hsp90 protein binding | molecular function | Binding to Hsp90 proteins, any of a group of heat shock proteins around 90kDa in size. [GOC:ai] |
dynein complex binding | molecular function | Binding to a dynein complex, a protein complex that contains two or three dynein heavy chains and several light chains, and has microtubule motor activity. [GOC:bf, GOC:BHF, GOC:mah] |
transcription factor binding | molecular function | Binding to a transcription factor, a protein required to initiate or regulate transcription. [ISBN:0198506732] |
Located In
This protein is located in 17 target(s):
Target | Category | Definition |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
nucleoplasm | cellular component | That part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653] |
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
multivesicular body | cellular component | A type of endosome in which regions of the limiting endosomal membrane invaginate to form internal vesicles; membrane proteins that enter the internal vesicles are sequestered from the cytoplasm. [PMID:11566881, PMID:16533950] |
centrosome | cellular component | A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle. [GOC:mah, ISBN:0198547684] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
microtubule | cellular component | Any of the long, generally straight, hollow tubes of internal diameter 12-15 nm and external diameter 24 nm found in a wide variety of eukaryotic cells; each consists (usually) of 13 protofilaments of polymeric tubulin, staggered in such a manner that the tubulin monomers are arranged in a helical pattern on the microtubular surface, and with the alpha/beta axes of the tubulin subunits parallel to the long axis of the tubule; exist in equilibrium with pool of tubulin monomers and can be rapidly assembled or disassembled in response to physiological stimuli; concerned with force generation, e.g. in the spindle. [ISBN:0879693568] |
caveola | cellular component | A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm. [GOC:mah, ISBN:0721662544, PMID:16645198] |
inclusion body | cellular component | A discrete intracellular part formed of aggregated molecules such as proteins or other biopolymers. [GOC:mah, PMID:11121744] |
aggresome | cellular component | An inclusion body formed by dynein-dependent retrograde transport of an aggregated protein on microtubules. [PMID:11121744] |
axon | cellular component | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. [GOC:nln, ISBN:0198506732] |
dendrite | cellular component | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. [GOC:aruk, GOC:bc, GOC:dos, GOC:mah, GOC:nln, ISBN:0198506732] |
cell leading edge | cellular component | The area of a motile cell closest to the direction of movement. [GOC:pg] |
ciliary basal body | cellular component | A membrane-tethered, short cylindrical array of microtubules and associated proteins found at the base of a eukaryotic cilium (also called flagellum) that is similar in structure to a centriole and derives from it. The cilium basal body is the site of assembly and remodeling of the cilium and serves as a nucleation site for axoneme growth. As well as anchoring the cilium, it is thought to provide a selective gateway regulating the entry of ciliary proteins and vesicles by intraflagellar transport. [GOC:cilia, GOC:clt, PMID:21750193] |
perikaryon | cellular component | The portion of the cell soma (neuronal cell body) that excludes the nucleus. [GOC:jl] |
perinuclear region of cytoplasm | cellular component | Cytoplasm situated near, or occurring around, the nucleus. [GOC:jid] |
axon cytoplasm | cellular component | Any cytoplasm that is part of a axon. [GO_REF:0000064, GOC:TermGenie, PMID:18667152] |
Part Of
This protein is part of 2 target(s):
Target | Category | Definition |
histone deacetylase complex | cellular component | A protein complex that possesses histone deacetylase activity. [GOC:mah] |
microtubule associated complex | cellular component | Any multimeric complex connected to a microtubule. [GOC:jl] |
Involved In
This protein is involved in 59 target(s):
Target | Category | Definition |
protein polyubiquitination | biological process | Addition of multiple ubiquitin groups to a protein, forming a ubiquitin chain. [ISBN:0815316194] |
response to amphetamine | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amphetamine stimulus. Amphetamines consist of a group of compounds related to alpha-methylphenethylamine. [GOC:dph, GOC:ef] |
protein deacetylation | biological process | The removal of an acetyl group from a protein amino acid. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid. [GOC:ai] |
protein quality control for misfolded or incompletely synthesized proteins | biological process | The chemical reactions and pathways resulting in the breakdown of misfolded or attenuated proteins. [GOC:jl] |
intracellular protein transport | biological process | The directed movement of proteins in a cell, including the movement of proteins between specific compartments or structures within a cell, such as organelles of a eukaryotic cell. [GOC:mah] |
autophagy | biological process | The cellular catabolic process in which cells digest cellular materials, such as organelles and other macromolecular constituents, or non-self materials such as intracellular pathogens. Autophagy serves to provide essential nutrients under conditions of cellular stress; or can remodel intracellular structures during cell differentiation. [GOC:autophagy, ISBN:0198547684, PMID:11099404, PMID:29455577, PMID:9412464] |
actin filament organization | biological process | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments. Includes processes that control the spatial distribution of actin filaments, such as organizing filaments into meshworks, bundles, or other structures, as by cross-linking. [GOC:mah] |
negative regulation of microtubule depolymerization | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule depolymerization; prevention of depolymerization of a microtubule can result from binding by 'capping' at the plus end (e.g. by interaction with another cellular protein of structure) or by exposing microtubules to a stabilizing drug such as taxol. [GOC:mah, ISBN:0815316194] |
regulation of autophagy | biological process | Any process that modulates the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. [GOC:dph, GOC:tb] |
positive regulation of epithelial cell migration | biological process | Any process that activates or increases the frequency, rate or extent of epithelial cell migration. [GOC:BHF, GOC:dph, GOC:tb] |
negative regulation of hydrogen peroxide metabolic process | biological process | Any process that decreases the frequency, rate or extent of the chemical reactions and pathways involving hydrogen peroxide. [GOC:dph, GOC:hjd, GOC:tb] |
regulation of macroautophagy | biological process | Any process that modulates the frequency, rate or extent of macroautophagy. [GOC:krc] |
axonal transport of mitochondrion | biological process | The directed movement of mitochondria along microtubules in nerve cell axons. [GOC:ai] |
negative regulation of protein-containing complex assembly | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex assembly. [GOC:mah] |
regulation of protein stability | biological process | Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation. [GOC:dph, GOC:mah, GOC:tb] |
protein destabilization | biological process | Any process that decreases the stability of a protein, making it more vulnerable to degradative processes or aggregation. [GOC:mah] |
lysosome localization | biological process | Any process in which a lysosome is transported to, and/or maintained in, a specific location. [GOC:mah] |
protein-containing complex disassembly | biological process | The disaggregation of a protein-containing macromolecular complex into its constituent components. [GOC:mah] |
positive regulation of peptidyl-serine phosphorylation | biological process | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. [GOC:mah] |
cellular response to heat | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. [GOC:mah] |
peptidyl-lysine deacetylation | biological process | The removal of an acetyl group from an acetylated lysine residue in a peptide or protein. [GOC:BHF, GOC:mah] |
response to immobilization stress | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of being rendered immobile. [GOC:bf, PMID:17683801, PMID:19893991] |
cellular response to topologically incorrect protein | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a protein that is not folded in its correct three-dimensional structure. [GOC:bf] |
erythrocyte enucleation | biological process | The process in which nucleated precursor cells lose their nucleus during erythrocyte maturation. [GOC:hjd] |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | biological process | The chemical reactions and pathways resulting in the breakdown of a protein or peptide covalently tagged with ubiquitin, via the multivesicular body (MVB) sorting pathway; ubiquitin-tagged proteins are sorted into MVBs, and delivered to a lysosome/vacuole for degradation. [GOC:jl, PMID:11511343] |
negative regulation of protein-containing complex disassembly | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components. [GOC:jl] |
regulation of fat cell differentiation | biological process | Any process that modulates the frequency, rate or extent of adipocyte differentiation. [GOC:go_curators] |
negative regulation of gene expression, epigenetic | biological process | An epigenetic process that silences gene expression at specific genomic regions through chromatin remodeling either by modifying higher order chromatin fiber structure, nucleosomal histones, or the cytosine DNA methylation. [PMID:22243696] |
negative regulation of proteolysis | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein. [GOC:go_curators] |
negative regulation of DNA-templated transcription | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. [GOC:go_curators, GOC:txnOH] |
collateral sprouting | biological process | The process in which outgrowths develop from the shafts of existing axons. [GOC:dgh, GOC:dph, GOC:jid, GOC:lm] |
negative regulation of axon extension involved in axon guidance | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of axon extension involved in axon guidance. [GOC:devbiol] |
positive regulation of dendrite morphogenesis | biological process | Any process that activates or increases the frequency, rate or extent of dendrite morphogenesis. [GOC:ai] |
negative regulation of oxidoreductase activity | biological process | Any process that stops or reduces the rate of oxidoreductase activity, the catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. [GOC:ai] |
response to corticosterone | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosterone stimulus. Corticosterone is a 21 carbon steroid hormone of the corticosteroid type, produced in the cortex of the adrenal glands. In many species, corticosterone is the principal glucocorticoid, involved in regulation of fuel metabolism, immune reactions, and stress responses. [PMID:15240347] |
response to misfolded protein | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a misfolded protein stimulus. [GOC:go_curators] |
positive regulation of synaptic transmission, glutamatergic | biological process | Any process that activates, maintains or increases the frequency, rate or extent of glutamatergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate. [GOC:ai] |
cilium assembly | biological process | The assembly of a cilium, a specialized eukaryotic organelle that consists of a filiform extrusion of the cell surface. Each cilium is bounded by an extrusion of the cytoplasmic membrane, and contains a regular longitudinal array of microtubules, anchored basally in a centriole. [GOC:BHF, GOC:cilia, GOC:dph, GOC:kmv, GOC:pr, GOC:vw, ISBN:0198506732, PMID:13978319, PMID:27350441, Reactome:R-HSA-5617833.2] |
regulation of microtubule-based movement | biological process | Any process that modulates the rate, frequency, or extent of microtubule-based movement, the movement of organelles, other microtubules and other particles along microtubules, mediated by motor proteins. [GOC:dph, GOC:tb] |
regulation of androgen receptor signaling pathway | biological process | Any process that modulates the rate, frequency, or extent of the androgen receptor signaling pathway. [GOC:dph] |
dendritic spine morphogenesis | biological process | The process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission. [GOC:dph] |
cilium disassembly | biological process | A cellular process that results in the breakdown of a cilium. [GOC:cilia, GOC:dph, PMID:17604723, PMID:27350441] |
parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization | biological process | A positive regulation of the macromitophagy pathway that is triggered by mitochondrial depolarization and requires the function of a parkin-family molecule. [GOC:autophagy, GOC:dph, GOC:pad, GOC:PARL, PMID:25349190] |
regulation of establishment of protein localization | biological process | Any process that modulates the frequency, rate or extent of the directed movement of a protein to a specific location. [GOC:BHF, GOC:mah] |
cellular response to hydrogen peroxide | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. [CHEBI:16240, GOC:mah] |
aggresome assembly | biological process | The aggregation, arrangement and bonding together of a set of components to form an aggresome; requires the microtubule cytoskeleton and dynein. [GOC:BHF, GOC:rl, PMID:14675537] |
polyubiquitinated misfolded protein transport | biological process | The directed movement of misfolded polyubiquitinated proteins in a cell, including the movement of proteins between specific compartments or structures within a cell. [GOC:BHF, GOC:mah, PMID:14675537] |
response to growth factor | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus. [GOC:BHF, GOC:mah] |
cellular response to misfolded protein | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a misfolded protein stimulus. [GOC:mah] |
cellular response to parathyroid hormone stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a parathyroid hormone stimulus. [GOC:mah] |
response to dexamethasone | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus. [GOC:mah, GOC:yaf] |
tubulin deacetylation | biological process | The removal of an acetyl group from tubulin. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid. [GOC:BHF, GOC:dph, GOC:tb] |
positive regulation of tubulin deacetylation | biological process | Any process that increases the frequency, rate or extent of tubulin deacetylation. Tubulin deacetylation is the removal of an acetyl group from a protein amino acid. [GOC:BHF, GOC:dph, GOC:tb] |
positive regulation of cellular response to oxidative stress | biological process | Any process that activates or increases the frequency, rate or extent of cellular response to oxidative stress. [GOC:mah, GOC:TermGenie] |
negative regulation of protein acetylation | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of protein acetylation. [GOC:TermGenie, PMID:22117195] |
regulation of autophagy of mitochondrion | biological process | Any process that modulates the frequency, rate or extent of mitochondrion degradation by an autophagic process. [GO_REF:0000058, GOC:autophagy, GOC:bf, GOC:PARL, GOC:TermGenie, PMID:24600391] |
positive regulation of cholangiocyte proliferation | biological process | Any process that activates or increases the frequency, rate or extent of cholangiocyte proliferation. [GO_REF:0000058, GOC:TermGenie, PMID:24434010] |
negative regulation of aggrephagy | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of aggrephagy. [GO_REF:0000058, GOC:pad, GOC:PARL, GOC:TermGenie, PMID:25686248] |
epigenetic regulation of gene expression | biological process | A process that modulates the frequency, rate or extent of gene expression through chromatin remodeling either by modifying higher order chromatin fiber structure, nucleosomal histones, or cytosine methylation of DNA. Once established, this regulation may be maintained over many cell divisions. It can also be heritable in the absence of the instigating signal. [PMID:10521337, PMID:11498582, PMID:22243696, PMID:34414474] |